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NON-PARAMETRIC INFERENCE AND REGRESSION ANALYSIS FOR
CUMULATIVE INCIDENCE FUNCTION UNDER TWO-STAGE
RANDOMIZATION
Idil Yavuz, PhD
University of Pittsburgh, 2013
In recent years, personalized medicine and dynamic treatment regimes have drawn consid-
erable attention and two-stage randomization is commonly used to gather data for making
inference on dynamic treatment regimes. Meanwhile, more and more practitioners become
aware of competing risk censoring, where subjects are exposed to more than one possible
failure and the event of interest may be dependently censored by the occurrence of competing
events.
We aim to compare several treatment regimes from a two-stage randomized trial on sur-
vival outcomes that are subject to competing-risk censoring. With the presence of competing
risks, cumulative incidence function (CIF) has been widely used to quantify the cumulative
probability of occurrence of the target event by a specific time point.
In the first part of this dissertation, we propose non-parametric estimators for the CIF
using inverse weighting, and provide inference procedures based on the asymptotic linear
representation to help compare the CIFs from two different treatment regimes. Through
simulation, we show the practicality and advantages of the proposed estimators and apply
them to data from the Cancer and Leukemia Group B (CALGB) trial.
Next, we propose a pattern-mixture type estimator for the CIF. Pattern-mixture models
stratify data according to dropout patterns, make estimates of a certain parameter on each
stratum, and obtain the final estimate by taking a weighted average of these estimates.
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We show that this approach can be borrowed for estimating the CIF under a two-stage
randomization. We investigate its properties using simulation and apply it to the CALGB
data.
In the third part, we focus on regression analysis under a two-stage randomization setting.
Even though extensive research is being carried out by researchers on the regression problem
for dynamic treatment regimes, no research has been done on modeling the CIF when a two-
stage randomization has been carried out. We extend the multi-state (Cheng et al., 1998),
Fine and Gray (1999) and Scheike et al. (2008) regression models for modeling the CIF of
dynamic treatment regimes and provide ways to implement the proposed models in R using
the existing packages. We show the improvement our methods provide by simulation.
Keywords: competing risks, cumulative incidence function, dynamic treatment regime, in-
verse weighting, multi-state model, pattern-mixture models, proportional hazards for
subdistribution, regression analysis, time-varying effects, two-stage randomization.
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1.0 INTRODUCTION
Dynamic treatment regime is a set of rules that guides treatment according to the patients’
needs, observed covariates and intermediate responses. The idea is to find the regime that
in the end produces the best outcome, where the best outcome can be the longest survival
time or the biggest reduction in some pre-specified score. To achieve this goal, two-stage
randomization designs have been used by researchers and have become more popular in
cancer, AIDS and psychiatric studies. Designing such studies and methods for analyzing
data that arise from these designs have been greatly studied in recent years.
In this dissertation, we focus on analyzing the data from two-stage randomization trials
for a survival outcome that is subject to competing-risk censoring. Competing-risk censoring
refers to a situation where subjects in a study are exposed to more than one possible failure
and the specific event of interest may be dependently censored by the occurrence of compet-
ing events. Competing-risk censoring is more natural than assuming the censoring due to
other events is independent, as a result this type of setting is gaining more attention from
practitioners when analyzing time-to-event data (Koller et al., 2012). When a subject is
exposed to more than one risk, we are then interested in the probability of occurrence of the
event of interest at a specific time point, or the cumulative incidence function (CIF). This
quantity is intuitively interpretable and non-parametrically identifiable, hence it has been
commonly used in the competing risks literature (Kalbfleisch and Prentice, 2002). When
competing risks are present and a two-stage randomization design is being used, the objec-
tive then would become finding a regime which results in a reduced probability of occurrence
of the event of interest. Although methods for analyzing time-to-event data that arise from
two-stage randomization designs have been developed when there is only one cause for fail-
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ure, no research has been carried out on how to analyze data from such designs under a
competing risks setting.
In this dissertation, we will first propose inverse weighted estimators that can be used for
estimating the CIF of dynamic treatment regimes. We will then give inference procedures
that can be used for comparing two regimes. Through simulation we will show that the
proposed estimators are unbiased and they all out-perform the standard estimator na¨ıvely
applied to data from subjects consistent with a specific regime.
In the second part of this dissertation, we propose another estimator for the CIF which
can be used when dynamic treatment regimes are of concern, following ideas of pattern-
mixture models. This pattern-mixture estimator is straightforward with a simple explicit
variance estimator. We show the unbiasedness and good performance of this estimator
through simulation.
Finally, we will examine the situation where covariates are involved and when competing
risks are present. It is of practical interest to examine how covariates may affect the CIF
for a specific regime. Although several regression models have been proposed for estimating
the CIF, none can be directly applied in a two-stage randomization design. We will propose
two methods to improve current models and provide extensive simulation results.
2
2.0 NON-PARAMETRIC INFERENCE FOR THE CUMULATIVE
INCIDENCE FUNCTION UNDER TWO-STAGE RANDOMIZATION
2.1 INTRODUCTION
In dynamic treatment regimes, the treatment level and type can vary depending on evolving
measurements of subject-specific need for treatment. These regimes are rules that provide
treatment adapted to individual needs, thus they are more cost effective and they improve
patient’s compliance by avoiding over-treatment or under-treatment (Lavori and Dawson,
2000). Different designs of clinical trials can be used for estimating the treatment efficacy
of various treatment regimes. The simplest one is the single stage randomization design
where the patients are randomized to all possible treatment regimes upon entry into the
trial. However, this method is not cost effective and in general requires a larger sample
size. The second way is to conduct multiple separate trials for the first and second stages
but this raises issues about patient comparability between trials. A better design is the so-
called Sequential Multiple Assignment Randomized Trial (SMART) which was considered
by Lavori and Dawson (2000), Lavori and Dawson (2004), Murphy (2005) and Murphy
et al. (2007), where patients are randomized to the initial treatment options at entry and
those continuing to the next stage are randomized to available treatment options based on
their intermediate response to the initial treatment and randomization is continued in this
fashion. For example, in a two-stage randomization design, suppose there are two treatment
options A1 and A2 at the first stage, and two treatment options for both responders and
non-responders namely B1 and B2 and B
′
1 and B
′
2 at the second stage. Using the SMART
strategy the randomization can be carried out as shown in Figure1.
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Figure 1: A two-stage randomization setup
Statistical methods for analyzing data from a SMART design are available in the lit-
erature. For example, Murphy et al. (2001) developed a marginal mean model for the
mean response of a dynamic treatment regime after which they provided a methodology for
constructing an optimal regime (Murphy, 2003). Lunceford et al. (2002) used the inverse
weighting method introduced by Robins et al. (1994) to propose a marginal mean model
(Murphy et al., 2001) for analyzing survival data from a two-stage setting. Later, Guo and
Tsiatis (2005) proposed a weighted risk-set estimator which is a modified Nelson-Aalen esti-
mator (Aalen, 1978). Although it may seem appropriate at first to apply the Kaplan-Meier
estimator (Kaplan and Meier, 1958) to the subgroup of patients following a specific regime,
Wahed and Tsiatis (2006) showed that such an estimator is biased, and to correct for this
bias they proposed a weighted version of the Kaplan-Meier estimator following Lunceford
et al. (2002) and Lokhnygina and Helterbrand (2007). Murphy and Bingham (2009) used
screening experiments to help develop dynamic treatment regimes.
Although the inference for dynamic treatment regimes has been studied in various articles
until now there has been no research on how to estimate the survival time for these regimes
under competing risks settings. Competing-risk censoring is common in practice when there
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are composite outcomes, and it has recently drawn more attention from practitioners (Gooley
et al., 1999; Klein, 2006; Koller et al., 2012). In competing risks settings, the cumulative
incidence function (CIF) is a commonly used quantity which describes the proportion of the
event of interest occurring over time in the presence of competing events (Kalbfleisch and
Prentice, 2002).
In this chapter, we show that the standard non-parametric estimator of the CIF, using
the data from only those subjects who are consistent with the treatment regime of interest,
may be biased. Instead, we propose several estimators of the CIF with various weight
functions, and compare them to the standard non-parametric estimator. After introducing
the necessary notation, defining the new estimators and proposing inference for comparison
of two regimes, we will present the findings from sets of simulations we ran and finally
demonstrate the practicality of the proposed methods by applying them to the CALG-B
data set.
2.2 SET-UP AND NOTATION
The design in Figure 1 would create a total of eight regimes AjBkB
′
l for j,k,l=1,2. Here
AjBkB
′
l stands for the regime where the subject is treated with Aj followed by Bk if the
subject responds to Aj and by B
′
l if not. Let Tjkl denote the survival time of a subject
following the regime AjBkB
′
l . The goal is then to estimate the probability that the event of
interest occurs before a specific time t where the subject may fail from any of the competing
events of failure. The survival distribution of a subject following the regime AjBkB
′
l is
Sjkl(t) = P (Tjkl > t) but estimating this overall survival will not provide detailed information
about the probabilities of interest thus the estimator recommended for this purpose is the
CIF.
Without loss of generality, we consider only the subjects that are assigned to treatment
A1 at first stage and assume there are only two causes of possible failures. It is easy to show
that adding extra layer of weight to account for those subjects who are initially assigned to
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A2 will not change the inference procedure, if the weight does not depend on covariates. For
the case where the weight does depend on covariates, Miyahara and Wahed (2010) pointed
out that there may not be much gain in efficiency in the inference of a survival outcome with
independent censoring, since covariates are most likely balanced due to randomization. In
addition, multiple competing events can be grouped together without affecting the analysis
for the event of interest. Therefore, limiting the number of causes of possible failure does
not affect the inference proposed.
For the ith subject (i = 1, · · · , n), let TRi be the time to intermediate response assessment
since the initial randomization, Ri be the response indicator (Ri=1 if the subject has re-
sponded to A1; 0 otherwise), Z1i be the second treatment assignment indicator for responders
(Z1i = k if subject is assigned to Bk; k = 1, 2), and Z2i be the second treatment assignment
indicator for non-responders (Z2i = l if subject is assigned to B
′
l ; l = 1, 2). Let Ti denote
the time to first event since the initial randomization and i denote the corresponding event
type (=1, if the first event is the event of interest, =2, if the competing event occurs first).
There may also be independent censoring present which can be written as Ci. Hence the
observed event time is Vi = min (Ti, Ci), and the cause indicator ∆i = iI(Ci ≥ Ti) takes
on the value of 1 or 2 if the cause 1 or 2 event occurs before censoring, and 0 if no event is
observed before Ci. Then, the i
th subject’s data can be represented as {TRi , Ri, RiZ1i, (1 −
Ri)Z2i, Vi,∆i}. Here, Tjkl is only observed for subjects who were on treatment Aj, responded
to it and received Bk or did not respond to Aj and received B
′
l , and not observed for
the others. The randomization probabilities piBk = Pr(Z1i = k | Ri = 1) and piB′l =
Pr(Z2i = l | Ri = 0) are assumed to be independent of the observed data prior to the second
randomization except for Ri. In some cases, the time to response may also be censored
but in such cases it is customary to treat the patients with censored response times as
non-responders (Lunceford et al., 2002).
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2.3 THE WEIGHTED ESTIMATORS OF THE CIF
2.3.1 The CIF Estimator with Fixed Weights
To estimate the cause 1 CIF for the regime A1BkB
′
l , k, l = 1, 2, one may na¨ıvely construct a
standard non-parametric estimator using the data only from those subjects whose treatments
are consistent with the regime (i.e., subjects who were on treatment A1, responded to it and
received Bk or did not respond to A1 and received B
′
l). Let t1 < t2 < · · · < tk be the distinct
event times where either the event of interest or the competing event occurs. Let Yi be the
number of subjects at risk, di be the number of subjects with the occurrence of the event
of interest, and ri be the number of subjects with the occurrence of the competing event at
time ti among patients who received Bk or B
′
l as second stage therapy. Then, the cause 1
CIF for the regime A1BkB
′
l would be estimated by
Fˆ1,A1BkB′l
(t) =
∑
ti≤t
di
Yi
{
i−1∏
j=1
(
1− dj + rj
Yj
)}
(2.3.1)
for t1 ≤ t and 0 otherwise. For t1 ≤ t the CIF can be represented as
Fˆ1,A1BkB′l
(t) =
∑
ti≤t
SˆA1BkB′l
(ti−)di
Yi
,
where SˆA1BkB′l
(ti−) is the Kaplan-Meier estimator (Kaplan and Meier, 1958) evaluated at
just before time ti. The variance estimator of Fˆ1,A1BkB′l
(t) is given in Klein and Moeschberger
(2003) as
σˆ2
(
Fˆ1,A1BkB′l
(t)
)
=
∑
ti≤t
(
SˆA1BkB′l
(ti)
2
{(
Fˆ1,A1BkB′l
(t)− Fˆ1,A1BkB′l (ti)
)2 ri + di
Y 2i
}
+SˆA1BkB′l
(ti)
2
[{
1− 2
(
Fˆ1,A1BkB′l
(t)− Fˆ1,A1BkB′l (ti)
)} di
Y 2i
])
.
The standard CIF estimator discards all the information from those subjects who are not
consistent with the regime A1BkB
′
l , hence it loses efficiency and may be biased. To account
for loss of those subjects, we take a similar approach used by Lunceford et al. (2002), Guo
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and Tsiatis (2005) and Miyahara and Wahed (2010), and propose a weighted cumulative
incidence function (WCIF) estimator
Fˆw
1,A1BkB
′
l
(t) =
∑
ti≤t
dwi
Y wi
{
i−1∏
j=1
(
1− d
w
j + r
w
j
Y wj
)}
, (2.3.2)
for t1 ≤ t and 0 otherwise, where dwi =
∑n
j=1 I(Vj = ti,∆j = 1)QA1BkB′l ,j
, rwi =
∑n
j=1 I(Vj =
ti,∆j = 2)QA1BkB′l ,j
and Y wi =
∑n
j=1 I(Vj ≥ ti)QA1BkB′l ,j for QA1BkB′l ,j = RjI{Z1j =
k}/piBk + (1 − Rj)I{Z2j = l}/piB′l . Recall that Z1j is the second treatment assignment
indicator for responders (Z1j = k if subject j is assigned to Bk; k = 1, 2), Z2j is the second
treatment assignment indicator for non-responders (Z2j = l if subject j is assigned to B
′
l ;
l = 1, 2), piBk = P (Z1j = k | Rj = 1) and piB′l = P (Z2j = l | Rj = 0). The CIF estima-
tor in (2.3.2) is similar to the standard estimator except that those subjects following the
regime are inversely weighted by the probability of being allocated to a specific treatment
option during the second stage to compensate for those subjects who have been assigned to
alternative treatments but could have been consistent with the regime if there had been no
second randomization.
To estimate the variance of Fˆw
1,A1BkB
′
l
, the following counting process formulation was
used. For subject j, define the weighted cause specific event processes Nw1j(s) = I(Vj ≤
s,∆j = 1)QA1BkB′l ,j
and Nw2j(s) = I(Vj ≤ s,∆j = 2)QA1BkB′l ,j, and the overall event pro-
cess Nwj (s) = N
w
1j(s) + N
w
2j(s). Also define the weighted at-risk process Y
w
j (s) = I(Vj ≥
s)QA1BkB′l ,j
. Summing over all subjects, we have Y w. (s) =
∑n
j=1 Y
w
j (s), N
w
1. (s) =
∑n
j=1N
w
1j(s)
similarly Nw2. (s), and N
w
. (s) = N
w
1. (s) + N
w
2. (s). Let Λ1(s) =
∫ s
0
λ1(u)du, where λk(u) =
limh→0
P (u≤V <u+h,∆=k|V≥u)
h
is the cause-specific hazard function for event k, and Λ(s) =∫ s
0
λ(u)du, where λ(u) = limh→0
P (u≤V <u+h|V≥u)
h
is the all-cause hazard. Let Mwj (s) =
Nwj (s) −
∫ s
0
Y wj (u)dΛ(u). One can show that M
w
j ’s are martingales and so is M
w
. (s) =
Nw. (s)−
∫ s
0
Y w. (u)dΛ(u). Similarly, M
w
1. (s) = N
w
1. (s)−
∫ s
0
Y w. (u)dΛ1(u) is also a martingale.
Using the counting process notation the weighted survival and the WCIF estimator can be
represented as follows:
Sˆw
A1BkB
′
l
(t) =
∏
s≤t
{
1− ∆N
w
. (s)
Y w. (s)
}
,
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Fˆw
1,A1BkB
′
l
(t) =
∫ t
0
Sˆw
A1BkB
′
l
(s−)dΛˆw1 (s),
where ∆Nw. (s) = N
w
. (s)−Nw. (s−), and Λˆw1 (s) =
∫ s
0
dNw1.(s)
Y w. (s)
.
To simplify the notation in what follows, we will temporarily drop the regime from the
notation by letting Fˆw
1,A1BkB
′
l
= Fˆw1 and let Sˆ
w
A1BkB
′
l
= Sˆw. To derive the variance of the
WCIF estimator, we write
√
n(Fˆw1 (t)− F1(t))
=
√
n
{∫ t
0
Sˆw(s−)dΛˆ1(s)−
∫ t
0
S(s−)dΛ1(s)
}
=
√
n
{∫ t
0
Sˆw(s−)dN
w
1. (s)
Y w. (s)
−
∫ t
0
Sˆw(s−)dΛ1(s) +
∫ t
0
(Sˆw(s−)− S(s−))dΛ1(s)
}
.(2.3.3)
Following Theorem 3.2.3 in Fleming and Harrington (1991) the ratio of the weighted survival
function and the survival function can be derived as follows:
Sˆw(t)
S(t)
=
Sˆw(0)
S(0)
−
∫ t
0
Sˆw(s−)
S(s)S(s−)dS(s) +
∫ t
0
1
S(s)
dSˆw(s)
= 1 +
∫ t
0
Sˆw(s−)
S(s)
dΛ(s)−
∫ t
0
Sˆw(s−)
S(s)
dΛˆ(s)
= 1−
∫ t
0
Sˆw(s−)
S(s)
{
dNw. (s)
Y w. (s)
− dΛ(s)
}
.
This can be used to obtain the difference between the weighted estimator and the survival
function as Sˆw(t)− S(t) = −S(t) ∫ t
0
Sˆw(s−)
S(s)
{
dNw. (s)
Y w. (s)
− dΛ(s)
}
. Plugging this into (2.3.3), we
can write
√
n(Fˆw1 (t)− F1(t))
=
√
n
∫ t
0
Sˆw(s−) 1
Y w. (s)
{dNw1. (s)− Y w. (s)dΛ1(s)}
−√n
∫ t
0
S(s)
{∫ s
0
Sˆw(u−)
S(u)
1
Y w. (u)
dMw. (u)
}
dΛ1(s)
=
√
n
∫ t
0
Sˆw(s−) 1∑n
i=1Qi
1
Y w. (s)∑n
i=1Qi
{dNw1. (s)− Y w. (s)dΛ1(s)}
−√n
∫ t
0
S(s)
{∫ s
0
Sˆw(u−)
S(u)
1∑n
i=1Qi
1
Y w. (u)∑n
i=1Qi
dMw. (u)
}
dΛ1(s)
=
1√
n
∫ t
0
n∑n
i=1 Qi
Sˆw(s−) 1
Y¯ w(s)
[dNw1. (s)− Y w. (s)dΛ1(s)]
− 1√
n
∫ t
0
n∑n
i=1Qi
S(s)
{∫ s
0
Sˆw(u−)
S(u)
1
Y¯ w(s)
dMw. (u)
}
dΛ1(s), (2.3.4)
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where Y¯ w(s) = Y
w(s)∑n
i=1Qi
. Using Taylor’s expansion on 1
Y¯ w(s)
, we can replace it with 1
S(s−) plus
a smaller order term. The first term in (2.3.4) can be written as
1√
n
n∑
j=1
∫ t
0
Sˆw(s−) 1
S(s−) [dN
w
1j(s)− Y wj (s)dΛ1(s)] + op(1) =
1√
n
n∑
j=1
I1j(t) + op(1).
Following a similar approach the second term in (2.3.4) can be written as
1√
n
n∑
j=1
∫ t
0
S(s)
[∫ s
0
Sˆw(u−)
S(u)
1
S(u−)(dN
w
j (u)− Y wj (u)dΛ(u))
]
dΛ1(s) + op(1)
=
1√
n
n∑
j=1
I2j(t) + op(1).
Thus,
√
n(Fˆw1 (t) − F1(t)) = 1√n
∑n
j=1 Ij(t) + op(1) where Ij(t) = I1j(t) − I2j(t). As a
result we obtain the following variance estimator for the weighted CIF estimator:
σˆ2(Fˆw1 (t)) =
1
n2
n∑
j=1
Iˆ2j (t),
where Iˆj(t) = Iˆ1j(t)− Iˆ2j(t) with
Iˆ1j(t) =
∫ t
0
dNw1j(s)− Y wj (s)dΛ1(s)
= Qj
∑
tm≤t
[
I(Vj = tm,∆j = 1)− I(Vj ≥ tm) d
w
m
Y wm
]
and
Iˆ2j(t) =
∫ t
0
Sˆw(s)
[∫ s
0
1
Sˆw(u)
(dNwj (u)− Y wj (u)dΛ(u))
]
dΛ1(s)
= Qj
∑
tm≤t
Sˆw(tm)
[∑
td≤tm
1
Sˆw(td)
(
I(Vj = td)− I(Vj ≥ td)d
w
d + r
w
d
Y wd
)]
dwm
Y wm
.
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2.3.2 The CIF Estimator with Estimated Fixed Weights
In practice, due to randomization, the proportion of subjects who responded to the initial
treatment A1 and were randomized to Bk may not be exactly the same as piBk . Similarly,
the proportion of subjects receiving B
′
l could be different from piB′l
. In some situations it
may be necessary to estimate the randomization probabilities for the second stage or the
sample proportion may provide better information about the randomization process than
the intended assignment probabilities. For these reasons, we also propose a weighted CIF
estimator where the weights are estimated using the sample proportions instead of true
probabilities:
Fˆ ew
1,A1BkB
′
l
(t) =
∑
ti≤t
dewi
Y ewi
{
i−1∏
j=1
(
1− d
ew
j + r
ew
j
Y ewj
)}
, (2.3.5)
for t1 ≤ t and 0 otherwise, where dewi =
∑n
j=1 I(∆j = 1)I(Vj = ti)QˆA1BkB′l ,j
, rewi =∑n
j=1 I(∆j = 2)I(Vj = ti)QˆA1BkB′l ,j
and Y ewi =
∑n
j=1 I(Vj ≥ ti)QˆA1BkB′lj for QˆA1BkB′l ,j =
RjI{Z1j = k}/pˆiBk + (1 − Rj)I{Z2j = l}/pˆiB′l . The variance of this estimator can be esti-
mated by replacing the weights with their estimated values in the formula derived for the
CI with fixed weights.
2.3.3 The CIF Estimators with Time-Dependent Weights
The proposed cumulative incidence functions with fixed weights and estimated fixed weights
can be improved in a way so that more subjects provide information for the estimation of
the cumulative incidence for a given regime. To do this, following the ideas from Guo and
Tsiatis (2005), subjects can be given weights of 1 until their response status are observed
because they remain consistent with all of the regimes. Once the response status is known
and the second randomization is carried out, the patients receive weights according to the
regimes they follow. The weights evaluated at time t can be written as below:
QA1BkB′l ,j
(t) =

1, if TRj > t,
RjI{Z1j=k}
piBk
+
(1−Rj)I{Z2j=l}
pi
B
′
l
, if TRj ≤ t.
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Using the time-dependent weights the cumulative incidence for a specific regime can be
estimated as
Fˆ tw
A1BkB
′
l
(t) =
∑
ti≤t
dtwi
Y twi
{
i−1∏
j=1
(
1− d
tw
j + r
tw
j
Y twj
)}
. (2.3.6)
Here Fˆ tw
A1BkB
′
l
denotes the estimated CIF with time-dependent weights and
dtwi =
n∑
j=1
I(∆j = 1)I(Vj = ti)QA1BkB′l ,j
(ti),
rtwi =
n∑
j=1
I(∆j = 2)I(Vj = ti)QA1BkB′l ,j
(ti),
Y twi =
n∑
j=1
I(Vj ≥ ti)QA1BkB′l ,j(ti).
The associated influence function can be obtained by a slight modification of the previous
influence function and the new variance estimator can be obtained just by replacing the two
parts of the influence function with the ones below:
Iˆ tw1j (t) = Qj(t)
∑
tm≤t
[
I(Vj = tm,∆j = 1)− I(Vj ≥ tm) d
tw
m
Y twm
]
Iˆ tw2j (t) = Qj(t)
∑
tm≤t
Sˆtw(tm)
[∑
td≤tm
1
Sˆtw(td)
(
I(Vj = td)− I(Vj ≥ td)d
tw
d + r
tw
d
Y twd
)]
dtwm
Y twm
.
The CIF estimator with estimated time-dependent weights Fˆ tew
A1BkB
′
l
and its variance
estimator can be obtained by replacing the weights in Fˆ tw
A1BkB
′
l
and its variance with the
estimated ones.
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2.4 COMPARING TWO REGIMES
2.4.1 Confidence Intervals and Confidence Bands
Suppose we are interested in comparing the two regimes A1B1B
′
1 and A1B1B
′
2 which share
some common path. We would then be interested in the difference D(t) = F1,A1B1B′1
(t) −
F1,A1B1B′2
(t). It can be consistently estimated by the difference between the two estimated
CIFs with time-dependent weights of the respective regimes, i.e., Dˆtw(t) = Fˆ tw
1,A1B1B
′
1
(t) −
Fˆ tw
1,A1B1B
′
2
(t). If we denote the influence function for the two regimes respectively as I
(1)
j (t)
and I
(2)
j (t), we can write:
√
n(Dˆtw(t)−D(t)) = 1√
n
n∑
j=1
{
I
(1)
j (t)− I(2)j (t)
}
+ op(1)
=
1√
n
n∑
j=1
IDj (t) + op(1).
Since IDj (t) can be easily estimated by Iˆ
D
j (t) = Iˆ
(1)
j (t) − Iˆ(2)j (t) and the variance of Dˆtw
can be estimated as σˆ2
Dˆ(t)
= 1
n2
∑n
j=1
{
IˆDj (t)
}2
, the 100(1−α)% confidence interval for D(t)
is {
Fˆ tw
1,A1B1B
′
1
(t)− Fˆ tw
1,A1B1B
′
2
(t)
}
± Zα/2σˆDˆ(t),
where P (N(0, 1) ≥ Zα/2) = α/2.
In addition to point-wise confidence intervals, confidence bands are often constructed for
functions of D(t) to determine the time regions where the two CIFs differ. We adapt Lin’s
re-sampling technique (Lin et al., 1994; Lin, 1997) following the guidelines of Zhang and Fine
(2008). More specifically, we consider a general transformation G(F1,A1B1B′1
(t), F1,A1B1B′2
(t)).
Let G(1)(u, v) = ∂G(u, v)/∂u and G(2)(u, v) = ∂G(u, v)/∂v be first-order partial derivatives
of G, and n1 and n2 be the numbers of subjects who are consistent with the regimes A1B1B
′
1
and A1B1B
′
2. We assume that ni/(n1 +n2)→ ρi as n1 +n2 →∞, where 0 < ρi < 1, i = 1, 2.
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Then the functional delta method gives that
√
n[G(Fˆ tw
1,A1B1B
′
1
(t), Fˆ tw
1,A1B1B
′
2
(t))−G(F1,A1B1B′1(t), F1,A1B1B′2(t))]
=
2∑
i=1
ni∑
j=1
ρ
−1/2
i G
(i)(F1,A1B1B′1
(t), F1,A1B1B′2
(t))n
−1/2
i I
(i)
j (t) + oP (1)
=
√
n
2∑
i=1
ni∑
j=1
I
(i)G
j + oP (1),
where I
(i)G
j can be estimated by Iˆ
(i)G
j = G
(i)(Fˆ tw
1,A1B1B
′
1
(t), Fˆ tw
1,A1B1B
′
2
(t))Iˆ
(i)
j (t)/ni.
Thus,
√
n[G(Fˆ tw
1,A1B1B
′
1
(t), Fˆ tw
1,A1B1B
′
2
(t)) − G(F1,A1B1B′1(t), F1,A1B1B′2(t)]) converges weakly
to a Gaussian process with a variance consistently estimated by:
ΣˆG(t) = n
2∑
i=1
ni∑
j=1
{Iˆ(i)Gj (t)}2.
Let Z
(b)
ij , i = 1, 2, j = 1, . . . , ni, b = 1, . . . , N be independent standard normal variates. Then
the simulated process
Jˆ (b)(t) =
√
n
2∑
i=1
ni∑
j=1
G(i)(Fˆ tw
1,A1B1B
′
1
(t), Fˆ tw
1,A1B1B
′
2
(t))Iˆ
(i)
j (t)Z
(b)
ij /ni
has the same limiting process as:
√
n[G(Fˆ tw
1,A1B1B
′
1
(t), Fˆ tw
1,A1B1B
′
2
(t))−G(F1,A1B1B′1(t), F1,A1B1B′2(t))].
Let Cα be 100(1− α)th percentile of
J¯ (b) = sup
t[τl,τu]
|Jˆ (b)(t)|,
for b = 1, . . . , N and [τl, τu] ⊂ [0, τ ]. Then 100(1 − α)% confidence bands for the transfor-
mation G(F1,A1B1B′1
(t), F1,A1B1B′2
(t)) are:
G(Fˆ tw
1,A1B1B
′
1
(t), Fˆ tw
1,A1B1B
′
2
(t))± Cα
√
ΣˆG(t)/n. (2.4.1)
In the simple case where G(u, v) = u− v the simulated process Jˆ (b) can be written as:
Jˆ (b) =
1√
n
n∑
j=1
{
Iˆ
(1)
j Z
(b)
1j − Iˆ(2)j Z(b)2j
}
and the variance estimator is ΣˆG(t) =
1
n
∑n
j=1
(
Iˆ
(1)
j − Iˆ(2)j
)2
. Now, the confidence bands can
be computed as in (2.4.1).
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2.4.2 Time-averaged Differences
In practice, one is often interested in summarizing the difference between two CIFs over
time to obtain a global measure of the difference between two treatment regimes. Let G
be some general distance measure. To combine information in G{F1,A1B1B′1(t), F1,A1B1B′2(t)}
over time, Zhang and Fine (2008) proposed weighted average summaries:
GM =
∫ τu
τl
G{F1,A1B1B′1(t), F1,A1B1B′2(t)}dW (t),
where W (t) > 0 is a deterministic weight function and
∫ τu
τl
dW (t) = 1. Following the ideas of
the weighted log-rank tests for censored survival data, one may consider the class of weights
based on the CIF calculated by pooling the data from both regimes. The estimator for the
time-averaged difference is:
GˆM =
∫ τu
τl
G{Fˆ tw
1,A1B1B
′
1
(t), Fˆ tw
1,A1B1B
′
2
(t)}dW (t).
Then
√
n(GˆM −GM) can be expressed as
=
√
n
∫ τu
τl
[G{Fˆ tw
1,A1B1B
′
1
(t), Fˆ tw
1,A1B1B
′
2
(t)} −G{F1,A1B1B′1(t), F1,A1B1B′2(t)}]dW (t)
=
√
n
2∑
i=1
ni∑
j=1
Iˆ
(i)GM
j + op(1),
where Iˆ
(i)GM
j =
∫ τu
τl
Iˆ
(i)G
j (t)dW (t). The asymptotic variance can then be estimated by ΣˆGM =
n
∑2
i=1
∑ni
j=1{Iˆ(i)GMj }2. For the case where G(u, v) = u− v, Iˆ(1)Gj (t) = Iˆ(1)j /n and Iˆ(2)Gj (t) =
−Iˆ(2)j /n. Inference can easily be carried out based on these influence functions.
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2.5 SIMULATION
Simulation studies were carried out to compare the proposed estimator to the standard
estimator under different conditions. In all simulations the study design explained in Figure
1 was used. Only the subjects who received the initial treatment A1 were considered since
the data obtained from these subjects is independent of the data obtained from the subjects
that were assigned to the other initial treatment A2. The comparisons were made under three
different scenarios. Namely, the data were generated at which 1) Z1i ∼ 2 − Bernoulli(0.5)
and Z2i ∼ 2 − Bernoulli(0.5), 2) Z1i ∼ 2 − Bernoulli(0.3) and Z2i ∼ 2 − Bernoulli(0.3)
(i.e. Z1i = 1 with probability 0.3 and Z1i = 2 with probability 0.7), and 3) Z1i = 1
and Z2i ∼ 2 − Bernoulli(0.5). Every model was repeated for n = 300, 700 and for cases
Ri ∼ Bernoulli(0.4) and Ri ∼ Bernoulli(0.7) and 4000 data sets were generated for each
setting.
For each combination, {(TRi , Ri, Z1i, Z2i, Vi,∆i), i = 1, . . . , n} were generated. More
specifically, TRi , the times to response, were generated from Exponential (0.20) and restricted
at 1 year. The times to death from the second randomization (T ∗A1Bki or T
∗
A1B
′
li
, k, l = 1, 2)
were drawn from different exponential distributions with the parameter values of 1 for the
sequence of treatments A1B1, 0.75 for the A1B2, 0.50 for the A1B
′
1 and 0.25 for the A1B
′
2
treatments. Following Miyahara and Wahed (2010), we then defined the overall survival
time for subject i as Ti = T
R
i +Ri{I(Z1i = 1)T ∗A1B1i + I(Z1i = 2)T ∗A1B2i}+ (1−Ri){I(Z2i =
1)T ∗
A1B
′
1i
+ I(Z2i = 2)T
∗
A1B
′
2i
}. The times to censoring Ci were generated from a Uni-
form (1.5, 2) which resulted in 9% censoring for P (R = 1) = 0.4 and 13% censoring for
P (R = 1) = 0.7. Only the results for the regimes A1B1B
′
1 and A1B1B
′
2 were given since the
results for other regimes were similar.
In the following tables, CI(t) stands for the na¨ıve estimate of the CIF in (2.3.1) evaluated
at time t, WCI(t) stands for the proposed estimate of the CIF with fixed weights in (2.3.2)
and WCI2(t) is the proposed weighted CIF estimate with estimated fixed weights in (2.3.5),
TWCI(t) is the estimate of the CIF with time-dependent weights in (2.3.6) and TWCI2(t)
is the CIF estimate with estimated time-dependent weights.
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It is worth noting that although one might think of the simulated sample sizes as large,
because only the data from a specific regime were used in the estimation process, the sample
used in the estimation of the CIF for a particular regime is significantly smaller than the
entire sample.
Table 1 shows the simulation results for Scenario-1. It can be seen that all methods pro-
duce comparable results to the standard estimator under both response rates. The coverage
rates for all estimators improve and get closer to the desired value 95% as n gets larger. The
results for the two regimes are similar. This is not surprising, as when piB1 = piB′1
= 0.5, the
responders receiving A1B1 and non-responders receiving A1B
′
1 are assigned approximately
equal weights in all the weighting schemes. The pseudo sample after weighting has roughly
the same mixture of responders and non-responders as the original sample. Therefore, the
weighted methods produce similar estimates to the na¨ıve estimator.
The simulation results for the second scenario can be seen in Table 2. Under the second
scenario, for the first regime A1B1B
′
1 the na¨ıve and weighted methods perform similarly due
to the fact that piB1 = piB′1
= 0.3. This is again not surprising, as when piB1 = piB′1
= 0.3, the
responders receiving A1B1 and non-responders receiving A1B
′
1 are assigned approximately
equal weight. As a result, the pseudo sample created for the first regime after weighting
has roughly the same mixture of responders and non-responders as the original sample.
Therefore, the weighted methods produce similar estimates to the na¨ıve estimator. However,
for the second regime A1B1B
′
2, the na¨ıve CIF estimator produces biased results. The na¨ıve
estimate is obtained based on the data from about 30% of responders who actually received
A1B1 and about 70% of non-responders who actually received A1B
′
2. However, the remaining
responders and non-responders could be equally qualified for receiving this treatment regime
if there were no second-stage randomization. The weighted methods roughly generate a
pseudo sample that represents all responders and non-responders, which in turn produce
more accurate estimates of the true CIF than the na¨ıve estimator. The coverage rates from
the proposed weighted methods improve as the sample size is increased unlike the standard
estimator. TWCI2 performs slightly better compared to the other proposed methods.
The results from the third scenario can be seen in Table 3. It can be clearly seen that
17
Table 1: Inverse weighting- Scenario-1: specific time point (t), probability of response (pr), true
cumulative incidence (True), mean of estimates (Mean), empirical standard deviation (σ), mean of
estimated standard deviations (σˆ), coverage rate of 95% confidence intervals (Cov)
A1B1B
′
1 A1B1B
′
2
n t pr Method True Mean σ σˆ Cov True Mean σ σˆ Cov
300 0.5 0.4 CI 0.185 0.185 0.032 0.032 0.941 0.248 0.248 0.036 0.036 0.946
WCI 0.185 0.032 0.031 0.938 0.248 0.036 0.035 0.940
WCI2 0.185 0.032 0.031 0.939 0.248 0.036 0.035 0.940
TWCI 0.185 0.031 0.031 0.939 0.248 0.035 0.035 0.940
TWCI2 0.185 0.031 0.031 0.941 0.248 0.035 0.035 0.940
0.7 CI 0.158 0.158 0.030 0.030 0.942 0.190 0.189 0.032 0.032 0.946
WCI 0.158 0.030 0.029 0.940 0.189 0.032 0.032 0.942
WCI2 0.158 0.030 0.029 0.939 0.189 0.032 0.031 0.943
TWCI 0.158 0.030 0.029 0.940 0.189 0.032 0.031 0.943
TWCI2 0.158 0.030 0.029 0.941 0.189 0.032 0.031 0.943
1 0.4 CI 0.342 0.342 0.038 0.041 0.960 0.389 0.389 0.041 0.042 0.961
WCI 0.342 0.038 0.038 0.948 0.389 0.041 0.039 0.942
WCI2 0.342 0.038 0.038 0.950 0.389 0.040 0.039 0.942
TWCI 0.342 0.038 0.039 0.950 0.389 0.040 0.040 0.946
TWCI2 0.342 0.038 0.039 0.951 0.389 0.040 0.040 0.947
0.7 CI 0.306 0.307 0.038 0.039 0.956 0.330 0.330 0.038 0.040 0.961
WCI 0.307 0.038 0.037 0.948 0.330 0.038 0.038 0.952
WCI2 0.307 0.038 0.037 0.947 0.330 0.037 0.038 0.953
TWCI 0.307 0.038 0.037 0.950 0.330 0.038 0.038 0.953
TWCI2 0.307 0.038 0.037 0.948 0.330 0.038 0.038 0.956
700 0.5 0.4 CI 0.185 0.185 0.031 0.032 0.946 0.248 0.248 0.035 0.036 0.949
WCI 0.185 0.031 0.031 0.944 0.248 0.035 0.035 0.942
WCI2 0.185 0.031 0.031 0.944 0.248 0.035 0.035 0.939
TWCI 0.185 0.031 0.031 0.944 0.248 0.035 0.035 0.941
TWCI2 0.185 0.031 0.031 0.946 0.248 0.035 0.035 0.942
0.7 CI 0.157 0.157 0.030 0.030 0.940 0.190 0.189 0.032 0.032 0.942
WCI 0.157 0.030 0.029 0.936 0.189 0.032 0.032 0.939
WCI2 0.157 0.030 0.029 0.935 0.189 0.032 0.032 0.940
TWCI 0.157 0.030 0.029 0.936 0.189 0.032 0.031 0.941
TWCI2 0.157 0.030 0.029 0.938 0.189 0.032 0.031 0.938
1 0.4 CI 0.342 0.342 0.038 0.041 0.964 0.389 0.389 0.040 0.043 0.962
WCI 0.342 0.038 0.038 0.952 0.389 0.040 0.039 0.944
WCI2 0.342 0.038 0.038 0.952 0.389 0.039 0.039 0.947
TWCI 0.342 0.038 0.039 0.956 0.389 0.040 0.040 0.949
TWCI2 0.342 0.038 0.039 0.955 0.389 0.039 0.040 0.952
0.7 CI 0.306 0.306 0.037 0.039 0.958 0.330 0.330 0.038 0.040 0.963
WCI 0.306 0.037 0.037 0.948 0.330 0.038 0.038 0.948
WCI2 0.306 0.037 0.037 0.949 0.330 0.038 0.038 0.948
TWCI 0.306 0.037 0.037 0.951 0.330 0.038 0.038 0.951
TWCI2 0.306 0.037 0.037 0.952 0.330 0.038 0.038 0.952
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Table 2: Inverse weighting- Scenario-2: specific time point (t), probability of response (pr), true
cumulative incidence (True), mean of estimates (Mean), empirical standard deviation (σ), mean of
estimated standard deviations (σˆ), coverage rate of 95% confidence intervals (Cov)
A1B1B
′
1 A1B1B
′
2
n t pr Method True Mean σ σˆ Cov True Mean σ σˆ Cov
300 0.5 0.4 CI 0.185 0.185 0.041 0.041 0.939 0.248 0.283 0.036 0.036 0.863
WCI 0.185 0.041 0.040 0.934 0.248 0.035 0.034 0.937
WCI2 0.185 0.041 0.040 0.934 0.248 0.035 0.034 0.940
TWCI 0.185 0.041 0.040 0.940 0.248 0.035 0.034 0.942
TWCI2 0.185 0.041 0.040 0.938 0.248 0.035 0.034 0.942
0.7 CI 0.158 0.158 0.038 0.038 0.943 0.190 0.229 0.038 0.038 0.846
WCI 0.158 0.038 0.038 0.938 0.190 0.036 0.035 0.935
WCI2 0.158 0.038 0.038 0.939 0.190 0.036 0.035 0.937
TWCI 0.158 0.038 0.037 0.940 0.190 0.035 0.034 0.936
TWCI2 0.158 0.038 0.038 0.940 0.190 0.035 0.035 0.936
1 0.4 CI 0.342 0.343 0.051 0.052 0.950 0.389 0.425 0.039 0.042 0.891
WCI 0.343 0.051 0.049 0.938 0.390 0.041 0.040 0.944
WCI2 0.343 0.051 0.049 0.941 0.390 0.041 0.040 0.946
TWCI 0.343 0.051 0.050 0.942 0.390 0.041 0.041 0.954
TWCI2 0.343 0.051 0.050 0.946 0.390 0.040 0.041 0.954
0.7 CI 0.306 0.307 0.049 0.050 0.947 0.330 0.370 0.043 0.043 0.882
WCI 0.307 0.049 0.048 0.934 0.331 0.045 0.043 0.938
WCI2 0.307 0.049 0.048 0.937 0.331 0.044 0.043 0.939
TWCI 0.307 0.049 0.048 0.940 0.331 0.044 0.044 0.943
TWCI2 0.307 0.049 0.048 0.942 0.330 0.044 0.044 0.943
700 0.5 0.4 CI 0.185 0.186 0.042 0.041 0.936 0.248 0.283 0.035 0.036 0.865
WCI 0.186 0.042 0.040 0.929 0.249 0.035 0.034 0.945
WCI2 0.186 0.042 0.040 0.930 0.249 0.034 0.034 0.948
TWCI 0.186 0.041 0.040 0.932 0.249 0.034 0.034 0.947
TWCI2 0.186 0.041 0.040 0.932 0.249 0.034 0.034 0.947
0.7 CI 0.158 0.158 0.039 0.038 0.931 0.190 0.228 0.037 0.038 0.858
WCI 0.158 0.039 0.038 0.924 0.190 0.035 0.035 0.938
WCI2 0.158 0.039 0.038 0.926 0.190 0.035 0.035 0.940
TWCI 0.158 0.039 0.037 0.932 0.189 0.035 0.034 0.938
TWCI2 0.158 0.039 0.037 0.930 0.189 0.035 0.035 0.938
1 0.4 CI 0.342 0.343 0.051 0.052 0.954 0.389 0.425 0.039 0.042 0.902
WCI 0.343 0.051 0.049 0.941 0.390 0.041 0.040 0.942
WCI2 0.343 0.051 0.049 0.940 0.390 0.041 0.040 0.944
TWCI 0.342 0.051 0.050 0.945 0.390 0.041 0.041 0.949
TWCI2 0.343 0.050 0.050 0.943 0.390 0.040 0.041 0.951
0.7 CI 0.306 0.306 0.049 0.050 0.954 0.330 0.369 0.043 0.045 0.898
WCI 0.306 0.049 0.048 0.942 0.330 0.044 0.043 0.938
WCI2 0.306 0.049 0.048 0.944 0.330 0.044 0.043 0.937
TWCI 0.306 0.049 0.048 0.945 0.330 0.043 0.044 0.943
TWCI2 0.306 0.049 0.048 0.948 0.329 0.043 0.044 0.944
19
Table 3: Inverse weighting- Scenario-3: specific time point (t), probability of response (pr), true
cumulative incidence (True), mean of estimates (Mean), empirical standard deviation (σ), mean of
estimated standard deviations (σˆ), coverage rate of 95% confidence intervals (Cov)
A1B1B
′
1 A1B1B
′
2
n t pr Method True Mean σ σˆ Cov True Mean σ σˆ Cov
300 0.5 0.4 CI 0.185 0.170 0.026 0.026 0.883 0.248 0.215 0.028 0.029 0.779
WCI 0.185 0.029 0.029 0.939 0.248 0.032 0.032 0.946
WCI2 0.185 0.029 0.029 0.940 0.249 0.032 0.032 0.949
TWCI 0.185 0.029 0.029 0.939 0.248 0.032 0.032 0.942
TWCI2 0.185 0.029 0.029 0.940 0.248 0.032 0.032 0.948
0.7 CI 0.158 0.147 0.022 0.022 0.905 0.190 0.166 0.023 0.023 0.811
WCI 0.158 0.025 0.025 0.935 0.190 0.027 0.027 0.939
WCI2 0.158 0.025 0.025 0.936 0.190 0.027 0.027 0.939
TWCI 0.158 0.025 0.025 0.938 0.190 0.027 0.027 0.939
TWCI2 0.158 0.025 0.025 0.938 0.190 0.027 0.027 0.941
1 0.4 CI 0.342 0.322 0.032 0.034 0.905 0.389 0.356 0.033 0.035 0.838
WCI 0.342 0.035 0.035 0.946 0.389 0.036 0.036 0.946
WCI2 0.342 0.035 0.035 0.946 0.389 0.036 0.036 0.948
TWCI 0.342 0.035 0.035 0.946 0.389 0.036 0.036 0.946
TWCI2 0.342 0.035 0.035 0.947 0.389 0.036 0.036 0.949
0.7 CI 0.306 0.292 0.028 0.029 0.924 0.330 0.306 0.028 0.030 0.881
WCI 0.307 0.031 0.031 0.945 0.330 0.031 0.031 0.950
WCI2 0.307 0.031 0.031 0.944 0.330 0.031 0.031 0.949
TWCI 0.307 0.031 0.031 0.945 0.330 0.031 0.031 0.948
TWCI2 0.307 0.031 0.031 0.946 0.330 0.031 0.031 0.950
700 0.5 0.4 CI 0.185 0.170 0.026 0.026 0.886 0.248 0.215 0.028 0.029 0.772
WCI 0.185 0.029 0.029 0.938 0.248 0.033 0.032 0.943
WCI2 0.185 0.029 0.029 0.940 0.248 0.033 0.032 0.944
TWCI 0.185 0.029 0.029 0.938 0.248 0.033 0.032 0.942
TWCI2 0.185 0.029 0.029 0.938 0.248 0.032 0.032 0.946
0.7 CI 0.158 0.147 0.022 0.022 0.899 0.190 0.166 0.023 0.023 0.802
WCI 0.158 0.025 0.025 0.940 0.190 0.028 0.027 0.939
WCI2 0.158 0.025 0.025 0.942 0.190 0.027 0.027 0.940
TWCI 0.158 0.025 0.025 0.940 0.190 0.028 0.027 0.936
TWCI2 0.158 0.025 0.025 0.942 0.190 0.027 0.027 0.940
1 0.4 CI 0.342 0.322 0.033 0.034 0.902 0.389 0.356 0.034 0.035 0.836
WCI 0.342 0.036 0.035 0.945 0.389 0.037 0.036 0.940
WCI2 0.342 0.036 0.035 0.945 0.389 0.036 0.036 0.941
TWCI 0.342 0.036 0.035 0.946 0.389 0.037 0.036 0.942
TWCI2 0.342 0.036 0.035 0.945 0.389 0.036 0.036 0.944
0.7 CI 0.306 0.292 0.029 0.029 0.914 0.330 0.306 0.029 0.030 0.874
WCI 0.307 0.031 0.031 0.942 0.331 0.032 0.031 0.942
WCI2 0.307 0.031 0.031 0.942 0.331 0.032 0.031 0.944
TWCI 0.307 0.032 0.031 0.943 0.331 0.032 0.031 0.941
TWCI2 0.307 0.031 0.031 0.945 0.331 0.032 0.031 0.942
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the na¨ıve estimator consistently produces biased estimates for both regimes. In contrast,
all proposed weighted methods are unbiased for both response rates and both regimes. The
coverage rates for the proposed methods are much better especially for the second regime
where the na¨ıve estimator coverage rate could go as low as 0.772 compared to TWCI2
achieving 0.946 under the same conditions.
2.6 DATA ANALYSIS
The proposed methods were applied to the data set from the Cancer and Leukemia Group
B (CALGB) trial which was a two-stage randomized trial conducted to evaluate the ef-
fects of adding granulocyte-macrophage colony-stimulating factor (GM-CSF) to standard
chemotherapy on elderly patients with leukemia (Stone et al., 1995). A total of 388 elderly
patients with acute myelogenous leukemia were enrolled and the study was double-blinded
and placebo-controlled. Upon entrance to the study 193 patients were randomized to the ini-
tial treatment where they received GM-CSF (A1) in addition to the standard chemotherapy
and 195 were randomized to the Chemo (A2) group where they received placebo in addition
to the standard chemotherapy. Response for this trial was defined as complete remission.
Responders were randomized so that at the second stage 37 GM-CSF and 45 Chemo respon-
ders received the maintenance therapy 1 (B1) and 42 GM-CSF and 45 Chemo responders
were randomized to the maintenance therapy 2 (B2). The non-responders were not random-
ized at the second stage. Therefore, there are a total of four regimes in this study A1B1,
A1B2, A2B1 and A2B2, where AkBl, k, l = 1, 2 denotes the treatment policy that a subject
started with Ak, and then received Bl if the subject responded and no further treatment if
the subject did not respond. Here, the fixed weight function for the regime A1Bk can be
written as
QA1Bki =
RiI(Z1i = k)
piBk
+ (1−Ri), k = 1, 2.
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Here piB1 = piB2 = 0.5 and the time-dependent weight function can be written as
QA1Bki(t) =
1, if I(T
R
i > t) = 1,
RiI(Z1i=k)
piBk
+ (1−Ri), if I(TRi > t) = 0,
for k = 1, 2.
Although data were available to these authors for only one type of failure, for those who
experienced an event and were not censored, we created a pseudo event type that was set
equal to 1 or 2 with probability 0.5 for the purpose of demonstrating the proposed methods.
We calculated the standard CIF estimator (CI), the CIF estimator with fixed weights (WCI)
and the CIF estimator with time-dependent weights (TWCI) for the cause 1 event of these
four regimes. The results are shown in Figure 2.
It can be seen from Figure 2 that the standard CIF estimator generally produces higher
estimates for the CIF and the two weighted estimators produce very similar results. If there
existed a type-1 event as we had simulated, we could then choose the regime that produces
the lowest probability of occurrence for type-1 event by comparing the CIF values for the
four regimes using the proposed weighted estimators. Since no such distinction exists in
failure types in this data, to recommend a treatment regime, survival probabilities must be
examined. We can obtain a weighted estimate for the overall survival function based on the
estimated cause 1 and cause 2 CIFs. That is,
SˆwAkBl(t) = 1− Fˆw1,AkBl(t)− Fˆw2,AkBl(t),
for k, l = 1, 2. The survival probabilities for the four regimes calculated using the above
formula are plotted in Figure 3. As it can be seen from this figure none of the regimes
clearly out-perform the others, which are consistent with the results from the weighted
survival estimates in Miyahara and Wahed (2010).
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Figure 2: Inverse weighted and na¨ıve CIF estimators for the four regimes.
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2.7 SUMMARY
In this chapter we proposed and compared different inverse weighted estimators of the CIF
which can be used when a two-stage randomization is carried out. The weighted methods
are easy to implement with explicit variance estimators. Therefore, we were able to provide
inference procedures to compare two treatment regimes and methods to obtain confidence
intervals and bands. We showed that the proposed estimators produce unbiased estimates
of the CIF with good coverage rates where the na¨ıve estimator fails to do so. In general,
the CIF estimator with estimated time-dependent weights produces slightly better results so
it should be preferred when possible. Since dynamic treatment regimes are widely used in
treating diseases that require complex treatment and competing-risk censoring is common in
studies with multiple endpoints, the proposed methods provide useful inferential tools that
will help advocate research in personalized medicine.
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3.0 A PATTERN-MIXTURE TYPE ESTIMATOR FOR THE
CUMULATIVE INCIDENCE FUNCTION UNDER TWO-STAGE
RANDOMIZATION
3.1 INTRODUCTION
Pattern-mixture models (Little, 1993) are widely used in longitudinal data analysis when
there are informative dropouts. The models yield a parameter estimate by first separat-
ing the data into different sections according to their dropout patterns, estimating the pa-
rameter on each section, and then combining these estimates as a weighted average. In
causal inference literature this approach where the overall parameter estimate is obtained
by first estimating the distribution of observed intermediate outcomes is referred to as the
G-computation algorithm (Robins, 1986, 1987). This algorithm was borrowed by Thall et al.
(2000) and Lavori and Dawson (2004) where they applied it to the analysis of data from
sequentially randomized trials. Later Wahed (2010) developed inference procedures for mean
survival times of two-stage adaptive treatment strategies using mixture distributions. Daw-
son and Lavori (2010) adapted the pattern-mixture models to sample size calculations for
the purpose of evaluating treatment policies when a mean-response was of concern. Wahed
and Tang (2013) utilized the pattern-mixture models to develop a Nelson-Aalen type esti-
mator for survival. They proposed parametric models for the survival functions of treatment
regimes, and tested for differences among these regimes.
In this chapter, we use similar ideas and propose a pattern-mixture type estimator for
the CIF to evaluate the effect of a two-stage treatment regime. We derive the explicit form
of its variance estimator and investigate the practical performance of this pattern-mixture
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estimator using simulation. The first set of simulations are similar to those in Section 2.5,
while the second set of simulations represent a case where the allocation probabilities may
depend on some pre-determined covariate. We compare the performance of the proposed
method to those of the inverse weighted and na¨ıve approaches.
3.2 A PATTERN-MIXTURE TYPE ESTIMATOR
Here we assume the same set-up as described in Section 2.2, where we focus on the four
treatment regimes that start with the initial treatment A1, namely A1BkB
′
l , k, l = 1, 2. The
notation remains the same as before. If we think about the cause 1 CIF for the regime
A1BkB
′
l as the conditional probability of a patient experiencing a type-1 event given the
patient following the specific regime, then it can be decomposed into the following two parts
based on the fact that the patient must have received either A1Bk, if the initial treatment
was working, or A1B
′
l , otherwise.
F1,A1BkB′l
(t) = P (T ≤ t,  = 1|A1BkB′l)
= P (R = 1)P (T ≤ t,  = 1|A1Bk) + {1− P (R = 1)}P (T ≤ t,  = 1|A1B′l)
= P (R = 1)F1,A1Bk(t) + {1− P (R = 1)}F1,A1B′l (t), (3.2.1)
where F1,A1Bk and F1,A1B′l
are the CIFs for treatment sequences of A1Bk and A1B
′
l , which
can be estimated directly based on the subjects who received these treatment combinations.
That is, to estimate F1,A1Bk , the standard non-parametric estimator of the CIF can be
constructed using only the subjects who received A1, responded to it and then received Bk.
Suppose there are M distinct event times for these subjects, t1 < t2 < · · · < tM . Let Yi
be the number of subjects at risk, di be the number of subjects with the occurrence of the
event of interest, and ri be the number of subjects having the competing event at time ti,
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i = 1, . . . ,M . Then the standard non-parametric estimator of the CIF is:
Fˆ1,A1Bk(t) =
∑
ti≤t
di
Yi
{
i−1∏
j=1
(
1− dj + rj
Yj
)}
=
∑
ti≤t
SˆA1Bk(ti−)
di
Yi
,
for t1 ≤ t and 0 otherwise, where Sˆ is the standard Kaplan-Meier estimator of the survival
function for time to first event, either cause 1 or cause 2. Fˆ1,A1B′l
(t) can be constructed
similarly.
For simplicity, we denote P (R = 1) = pr. This probability can easily be estimated by
the sample proportion, pˆr, which is the ratio of the number of responders to the number of
subjects who were initially assigned to A1. Plugging pˆr into the decomposition in (3.2.1)
gives rise to the following estimator of the CIF for the treatment regime A1BkB
′
l :
Fˆ pm
1,A1BkB
′
l
(t) = pˆrFˆ1,A1Bk(t) + (1− pˆr)Fˆ1,A1B′l (t), (3.2.2)
which is referred to as the pattern-mixture estimator of CIF (PMCIF) in the sequel. Esti-
mating the variance of Fˆ pm
1,A1BkB
′
l
(t) is straightforward because the standard non-parametric
estimators for Fˆ1,A1Bk(t) and Fˆ1,A1B′l
(t) have explicit variance estimators and Fˆ pm
1,A1BkB
′
l
(t) is
simply a linear combination of the two independent estimators. The estimated variance of
Fˆ1,A1Bk(t) is given in Klein and Moeschberger (2003) as
σˆ2
(
Fˆ1,A1Bk(t)
)
=
∑
ti≤t
(
SˆA1Bk(ti)
2
{(
Fˆ1,A1Bk(t)− Fˆ1,A1Bk(ti)
)2 ri + di
Y 2i
}
+SˆA1Bk(ti)
2
[{
1− 2
(
Fˆ1,A1Bk(t)− Fˆ1,A1Bk(ti)
)} di
Y 2i
])
.
The variance estimator of Fˆ1,A1B′l
(t) follows similarly. Therefore, the variance of Fˆ pm
1,A1BkB
′
l
can be estimated as follows:
σˆ2
(
Fˆ pm
1,A1BkB
′
l
(t)
)
= pˆr2σˆ2
(
Fˆ1,A1Bk(t)
)
+ (1− pˆr)2σˆ2
(
Fˆ1,A1B′l
(t)
)
. (3.2.3)
It is worthwhile to note that the proposed pattern-mixture approach and inverse weight-
ing approaches are equivalent for a continuous outcome Y without censoring. To demonstrate
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this, assume we are interested in the mean of this outcome for a specific dynamic treatment
regime A1BkB
′
l . Then, the pattern-mixture approach would suggest we estimate this mean
outcome as:
Y¯ pm = pˆr
1
nA1Bk
∑
iA1Bk
Yi + (1− pˆr) 1
nA1B′l
∑
iA1B
′
l
Yi
= pˆr
1
npˆrpˆiBk
∑
iA1Bk
Yi + (1− pˆr) 1
n(1− pˆr)pˆiB′l
∑
iA1B
′
l
Yi
=
1
n
 ∑
iA1Bk
Yi
pˆiBk
+
∑
iA1B
′
l
Yi
pˆiB′l
 = Y¯ ew,
where n, nA1Bk and nA1B′l
are the number of subjects receiving A1, A1Bk and A1B
′
l and
Y¯ pm and Y¯ ew represent the mean outcomes calculated using the pattern mixture approach
and inverse weighting respectively. However, the equivalence of the two approaches can
not be established analytically for time-to-event data where the event time is exposed to
competing risks. In the following section, we will show that the two approaches generate
almost equivalent results under various settings.
3.3 SIMULATION
3.3.1 A Simple Two Stage Randomization
Simulation studies were carried out to compare the proposed estimator to the na¨ıve estimator
and the inverse weighted estimators under different conditions. Again, only the subjects who
received the initial treatment A1 were considered since the data obtained from these subjects
are independent of the data obtained from the subjects that were assigned to the other initial
treatment A2. The comparisons were made under scenarios 2 and 3 as in Section 2.5, namely,
the data were generated at which 2) Z1i ∼ 2−Bernoulli(0.3) and Z2i ∼ 2−Bernoulli(0.3),
and 3) Z1i = 1 and Z2i ∼ 2 − Bernoulli(0.5). Every model was repeated for n = 300 and
for cases Ri ∼ Bernoulli(0.4) and Ri ∼ Bernoulli(0.7) and 4000 data sets were generated
for each setting.
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For each combination {(TRi , Ri, Z1i, Z2i, Vi,∆i), i = 1, . . . , n} were generated using the
same set-up as in Section 2.5 and only the results for the regimes A1B1B
′
1 and A1B1B
′
2 are
given since the results for other regimes were similar.
In the following tables CI(t) stands for the na¨ıve estimate of the CIF evaluated at time
t, WCI(t) stands for the inverse probability weighted estimate of the CIF with fixed weights
and WCI2(t) is the inverse weighted CIF estimate with estimated fixed weights , TWCI(t)
is the estimate of the CIF with time-dependent weights, TWCI2(t) is the CIF estimate with
estimated time-dependent weights, and PMCIF(t) is the pattern-mixture CIF estimate given
in (3.2.2).
Table 4 shows the simulation results for Scenario-2 and Scenario-3 with sample size
n = 300. For Scenario-2 all the estimators perform similarly for the first regime A1B1B
′
1
where they all produce unbiased estimates for the CIF at given times and they all have
coverage rates close to the desired value of 95%. For the PMCIF estimator it can be seen
that the straightforward variance estimator is working perfectly for both response rates. The
similarity of all estimators including the na¨ıve one is expected under this scenario due to
the randomization probabilities being equal, i.e. piB1 = piB′1
= 0.3. For the second regime
A1B1B
′
2, the na¨ıve estimator produces highly biased estimates which result in poor coverage
rates where all the other estimators are still unbiased and have desirable coverage rates for
both time points and both response rates.
For Scenario-3, the difference of the na¨ıve estimator versus the inverse weighted and
pattern-mixture estimators can be seen for both regimes at both time points. The na¨ıve
estimator stays biased with poor coverage rates under all conditions, while the pattern-
mixture estimator is unbiased with coverage rates close to 95% just like the inverse probability
weighted estimators.
3.3.2 Two Stage Randomization with Covariate Dependent Allocation
In practice, there may be information available suggesting that some treatment options
are more effective in treating certain diseases for certain subgroups of patients. If such
information is available, researchers may be inclined to design their experiments taking this
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Table 4: Pattern-mixture- Scenario-2 and Scenario-3 with n=300: specific time point (t), probability
of response (pr), true cumulative incidence (True), mean of estimates (Mean), empirical standard
deviation (σ), mean of estimated standard deviations (σˆ), coverage rate of 95% confidence intervals
(Cov)
A1B1B
′
1 A1B1B
′
2
Scenario t pr Method True Mean σ σˆ Cov True Mean σ σˆ Cov
2 0.5 0.4 CI 0.185 0.185 0.041 0.041 0.939 0.248 0.283 0.036 0.036 0.863
WCI 0.185 0.041 0.040 0.934 0.248 0.035 0.034 0.937
WCI2 0.185 0.041 0.040 0.934 0.248 0.035 0.034 0.940
TWCI 0.185 0.041 0.040 0.940 0.248 0.035 0.034 0.942
TWCI2 0.185 0.041 0.040 0.938 0.248 0.035 0.034 0.942
PMCIF 0.185 0.041 0.040 0.937 0.248 0.035 0.034 0.940
0.7 CI 0.158 0.158 0.038 0.038 0.943 0.190 0.229 0.038 0.038 0.844
WCI 0.158 0.038 0.038 0.938 0.190 0.036 0.035 0.935
WCI2 0.158 0.038 0.038 0.938 0.190 0.036 0.035 0.938
TWCI 0.158 0.038 0.037 0.940 0.190 0.035 0.034 0.936
TWCI2 0.158 0.038 0.038 0.940 0.190 0.035 0.035 0.937
PMCIF 0.158 0.038 0.038 0.939 0.190 0.035 0.035 0.937
1 0.4 CI 0.342 0.343 0.051 0.052 0.950 0.389 0.425 0.039 0.042 0.891
WCI 0.343 0.051 0.049 0.938 0.390 0.041 0.040 0.944
WCI2 0.343 0.051 0.049 0.941 0.390 0.041 0.040 0.946
TWCI 0.343 0.051 0.050 0.942 0.390 0.041 0.041 0.954
TWCI2 0.343 0.051 0.050 0.946 0.390 0.040 0.041 0.954
PMCIF 0.343 0.051 0.051 0.950 0.390 0.040 0.042 0.957
0.7 CI 0.306 0.307 0.049 0.050 0.947 0.330 0.370 0.043 0.045 0.882
WCI 0.307 0.049 0.048 0.934 0.331 0.045 0.043 0.937
WCI2 0.307 0.049 0.048 0.937 0.331 0.044 0.043 0.939
TWCI 0.307 0.049 0.048 0.940 0.331 0.044 0.044 0.942
TWCI2 0.307 0.049 0.048 0.942 0.330 0.044 0.044 0.943
PMCIF 0.307 0.049 0.049 0.944 0.331 0.044 0.045 0.948
3 0.5 0.4 CI 0.185 0.170 0.026 0.026 0.883 0.248 0.215 0.028 0.029 0.779
WCI 0.185 0.029 0.029 0.939 0.248 0.032 0.032 0.946
WCI2 0.185 0.029 0.029 0.940 0.249 0.032 0.032 0.949
TWCI 0.185 0.029 0.029 0.939 0.248 0.032 0.032 0.942
TWCI2 0.185 0.029 0.029 0.940 0.248 0.032 0.032 0.948
PMCIF 0.185 0.030 0.029 0.942 0.248 0.032 0.033 0.952
0.7 CI 0.157 0.147 0.022 0.022 0.908 0.190 0.166 0.023 0.023 0.816
WCI 0.158 0.025 0.025 0.935 0.190 0.027 0.027 0.940
WCI2 0.158 0.025 0.025 0.935 0.190 0.027 0.027 0.940
TWCI 0.158 0.025 0.025 0.938 0.190 0.027 0.027 0.939
TWCI2 0.158 0.025 0.025 0.939 0.190 0.027 0.027 0.941
PMCIF 0.158 0.025 0.025 0.936 0.190 0.027 0.027 0.941
1 0.4 CI 0.342 0.322 0.032 0.034 0.905 0.389 0.356 0.033 0.035 0.838
WCI 0.342 0.035 0.035 0.946 0.389 0.036 0.036 0.946
WCI2 0.342 0.035 0.035 0.946 0.389 0.036 0.036 0.948
TWCI 0.342 0.035 0.035 0.946 0.389 0.036 0.036 0.946
TWCI2 0.342 0.035 0.035 0.947 0.389 0.036 0.036 0.949
PMCIF 0.342 0.035 0.037 0.958 0.389 0.036 0.038 0.960
0.7 CI 0.306 0.292 0.028 0.029 0.925 0.330 0.306 0.028 0.030 0.880
WCI 0.307 0.031 0.031 0.945 0.330 0.031 0.031 0.950
WCI2 0.307 0.031 0.031 0.944 0.330 0.031 0.031 0.949
TWCI 0.307 0.031 0.031 0.945 0.330 0.031 0.031 0.948
TWCI2 0.307 0.031 0.031 0.946 0.330 0.031 0.031 0.950
PMCIF 0.307 0.031 0.032 0.953 0.330 0.031 0.032 0.956
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information into account and randomizing patients into treatments which they may be more
likely to benefit from. To investigate the performance of the proposed estimator under
such a setting, a covariate X was generated from a Bernoulli(0.5) to represent the gender
of a patient. As in previous section only the subjects who received the initial treatment
A1 were considered and all simulations were repeated 4000 times for cases n = 300 and
Ri ∼ Bernoulli(0.4) and Ri ∼ Bernoulli(0.7). Comparisons then were made under two
different scenarios.
For scenario-A, treatments B1 and B
′
1 are assumed to have higher chances of success for
females. For this reason, the females were given higher probabilities of being assigned to
these treatments depending on their response status. For men, the allocation was carried
out randomly with equal probability since no such information was available. If we let Z1f
and Z2f be the assignment indicators for females and Z1m and Z2m assignment indicators
for males, the randomization was carried out using Z1f ∼ 2 − Bernoulli(0.75), Z2f ∼
2−Bernoulli(0.75) and Z1m ∼ 2−Bernoulli(0.5), Z2m ∼ 2−Bernoulli(0.5).
The times to response, TRi , were generated from Exponential (0.20) and restricted at
1 year. The times to death from the second randomization (T ∗A1Bki or T
∗
A1B
′
li
, k, l = 1, 2)
were drawn from exponential distributions with different parameter values for females and
males. For females, the times to death were generated from exponential distributions with
parameter values of 1.25 for the sequence of treatments A1B1, 0.75 for the A1B2, 0.65 for
the A1B
′
1 and 0.25 for the A1B
′
2 treatments. For males, the times to death was generated
from exponential distributions with parameter values of 0.90 for the sequence of treatments
A1B1, 0.70 for the A1B2, 0.50 for the A1B
′
1 and 0.40 for the A1B
′
2 treatments. Censoring
time was generated from Uniform(1.5, 2) which resulted in approximately 12% censoring
for P (R = 1) = 0.4 and 16% censoring for P (R = 1) = 0.7 and the overall survival time was
calculated as given in Section 2.5 for each subject i.
For scenario-B, it is assumed that B1 works better for female responders than B2, and
B
′
2 works better for female non-responders than B
′
1, while the only information on males
is that B
′
2 works better for male non-responders than B
′
1. Therefore females were assigned
to B1 and B2
′ and males were assigned to B2′ with higher probabilities. More specifically
32
Z1f ∼ 2 − Bernoulli(0.75), Z2f ∼ 2 − Bernoulli(0.30) and Z1m ∼ 2 − Bernoulli(0.50),
Z2m ∼ 2−Bernoulli(0.30).
The times to response, TRi , were generated from Exponential (0.20) and restricted at 1
years. The times to death from the second randomization were again drawn from different
exponential distributions with different the parameter values for females and males. For
females, the times to death were generated from exponential distributions with parameter
values of 1.25 for the sequence of treatments A1B1, 0.75 for the A1B2, 0.25 for the A1B
′
1 and
0.65 for the A1B
′
2 treatments. For males, the times to death was generated from exponential
distributions with parameter values of 0.90 for the sequence of treatments A1B1, 0.70 for the
A1B2, 0.30 for the A1B
′
1 and 0.70 for the A1B
′
2 treatments. Censoring time was generated
from Uniform(1.5, 2) which resulted in approximately 13% censoring for P (R = 1) = 0.4
and 17% censoring for P (R = 1) = 0.7 and the overall survival time was calculated as given
in Section 2.5 for each subject i.
Table 5 shows the simulation results for Scenario-A and Scenario-B with sample size
n = 300. For Scenario-A, the na¨ıve estimator produces biased estimates for both regimes
under both response rates, performing worse for the second regime. The inverse probability
weighted estimators and the pattern-mixture estimator all perform as desired under all cases
and for both time points. For Scenario-B even though the na¨ıve estimator is unbiased for the
second regime, it still produces biased estimates for the first one. The proposed estimators
are again all unbiased and have much better coverage rates. In general, it can be seen
that under some cases, the variance estimator of the pattern-mixture estimator may tend to
slightly under-estimate the true variance, resulting in slightly lower coverage rates compared
to the inverse-weighted methods but overall the proposed methods are all highly preferable
to the na¨ıve approach.
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Table 5: Pattern-mixture- Scenario-A and Scenario-B with n=300, covariate dependent allocation:
specific time point (t), probability of response (pr), true cumulative incidence (True), mean of
estimates (Mean), empirical standard deviation (σ), mean of estimated standard deviations (σˆ),
coverage rate of 95% confidence intervals (Cov)
A1B1B
′
1 A1B1B
′
2
Scenario t pr Method True Mean σ σˆ Cov True Mean σ σˆ Cov
A 0.5 0.4 CI 0.172 0.168 0.028 0.027 0.934 0.224 0.196 0.033 0.033 0.837
WCI 0.171 0.029 0.028 0.937 0.224 0.039 0.039 0.942
WCI2 0.171 0.029 0.028 0.938 0.224 0.039 0.039 0.942
TWCI 0.171 0.029 0.028 0.940 0.223 0.039 0.038 0.940
TWCI2 0.171 0.029 0.028 0.940 0.223 0.039 0.039 0.941
PMCIF 0.171 0.029 0.028 0.938 0.224 0.039 0.039 0.940
0.7 CI 0.149 0.145 0.025 0.026 0.938 0.175 0.155 0.028 0.028 0.860
WCI 0.149 0.027 0.026 0.940 0.175 0.034 0.033 0.935
WCI2 0.149 0.027 0.026 0.940 0.175 0.034 0.033 0.936
TWCI 0.148 0.026 0.026 0.940 0.175 0.034 0.033 0.934
TWCI2 0.148 0.026 0.026 0.940 0.175 0.033 0.033 0.935
PMCIF 0.149 0.027 0.026 0.940 0.175 0.034 0.031 0.922
1 0.4 CI 0.325 0.321 0.035 0.036 0.954 0.371 0.341 0.041 0.042 0.875
WCI 0.326 0.036 0.035 0.945 0.370 0.045 0.043 0.936
WCI2 0.326 0.036 0.035 0.946 0.370 0.045 0.044 0.937
TWCI 0.326 0.035 0.035 0.948 0.370 0.045 0.044 0.941
TWCI2 0.326 0.035 0.035 0.950 0.370 0.045 0.044 0.940
PMCIF 0.326 0.036 0.036 0.951 0.371 0.045 0.044 0.943
0.7 CI 0.293 0.288 0.033 0.034 0.952 0.316 0.293 0.035 0.037 0.896
WCI 0.293 0.034 0.034 0.947 0.316 0.039 0.039 0.944
WCI2 0.293 0.034 0.034 0.947 0.316 0.039 0.039 0.943
TWCI 0.293 0.034 0.034 0.946 0.316 0.040 0.039 0.942
TWCI2 0.293 0.034 0.034 0.948 0.316 0.039 0.039 0.944
PMCIF 0.293 0.034 0.034 0.949 0.316 0.039 0.038 0.932
B 0.5 0.4 CI 0.238 0.202 0.035 0.034 0.806 0.158 0.158 0.026 0.026 0.946
WCI 0.238 0.041 0.041 0.941 0.158 0.026 0.026 0.945
WCI2 0.238 0.041 0.041 0.939 0.158 0.026 0.026 0.944
TWCI 0.237 0.041 0.041 0.939 0.158 0.026 0.026 0.945
TWCI2 0.237 0.041 0.041 0.940 0.158 0.026 0.026 0.945
PMCIF 0.238 0.042 0.041 0.937 0.158 0.026 0.026 0.942
0.7 CI 0.182 0.155 0.028 0.029 0.816 0.142 0.141 0.025 0.025 0.939
WCI 0.182 0.034 0.034 0.946 0.142 0.025 0.025 0.937
WCI2 0.182 0.034 0.034 0.944 0.142 0.025 0.025 0.939
TWCI 0.182 0.034 0.034 0.942 0.142 0.025 0.025 0.938
TWCI2 0.182 0.034 0.034 0.944 0.142 0.025 0.025 0.942
PMCIF 0.182 0.034 0.033 0.931 0.142 0.025 0.025 0.938
1 0.4 CI 0.381 0.341 0.042 0.044 0.844 0.309 0.308 0.033 0.034 0.953
WCI 0.380 0.047 0.045 0.940 0.308 0.033 0.033 0.944
WCI2 0.382 0.047 0.046 0.939 0.308 0.033 0.033 0.943
TWCI 0.379 0.047 0.046 0.942 0.308 0.033 0.033 0.946
TWCI2 0.379 0.047 0.046 0.944 0.308 0.033 0.033 0.945
PMCIF 0.380 0.047 0.046 0.941 0.308 0.033 0.033 0.949
0.7 CI 0.321 0.291 0.035 0.037 0.866 0.285 0.283 0.031 0.033 0.957
WCI 0.321 0.040 0.040 0.948 0.285 0.032 0.033 0.952
WCI2 0.321 0.039 0.040 0.950 0.285 0.032 0.033 0.953
TWCI 0.321 0.040 0.040 0.949 0.285 0.032 0.033 0.952
TWCI2 0.321 0.040 0.040 0.952 0.285 0.032 0.033 0.953
PMCIF 0.321 0.040 0.039 0.941 0.285 0.032 0.033 0.954
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3.4 DATA ANALYSIS
The proposed pattern-mixture type estimator was applied to the data set from the Cancer
and Leukemia Group B (CALGB) trial (Stone et al., 1995) which was explained in Section
2.7. The pseudo event types created in Section 2.7 were recorded and for the purpose of
demonstrating this method and comparing it to the inverse weighted and the na¨ıve methods,
the same pseudo event type values were used. We calculated the standard CIF estimator (CI),
the CIF estimator with fixed weights (WCI) and the pattern-mixture type CIF estimator
(PMCIF) for the cause 1 event of the four regimes. The results are shown in Figure 4.
It can be seen from Figure 4 that the standard CIF estimator generally produces higher
estimates for the CIF and the inverse weighted estimator and the pattern-mixture estimator
produce very similar results. We can also obtain a weighted estimate for the overall survival
function based on the estimated cause-1 and cause-2 PMCIFs. That is,
SˆpmAkBl(t) = 1− Fˆ pm1,AkBl(t)− Fˆ pm2,AkBl(t),
for k, l = 1, 2. The survival probabilities for the four regimes calculated using the above
formula are plotted in Figure 5. It can be seen that the estimated survival probabilities
using the pattern-mixture approach are quite similar to the survival probabilities obtained
using the inverse weighting approach which are plotted in Figure 3. As before, none of the
treatment regimes clearly out perform the others.
3.5 SUMMARY
In this chapter, we proposed a pattern-mixture type estimator for the CIF which can be
used when a two-stage randomization is carried out and the outcome of interest is subject
to competing-risk censoring. The application of the proposed method is straightforward
using existing packages in R and it has an explicit variance estimator making inference
simple. We showed that the proposed estimator produces unbiased estimates for the CIF
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Figure 4: Pattern-mixture, inverse weighted and na¨ıve CIF estimators for the four regimes.
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with good coverage rates where the na¨ıve estimator fails to do so. In general, it can be
seen that the pattern-mixture estimator produces very similar results to those obtained by
inverse weighting even when a covariate is involved in the allocation process. One possible
limitation of this method is that the sample size needs to be sufficiently large within each
stratum, as in any stratified data analysis technique. When there are only a few subjects
in a stratified group, the estimation of the CIF may not be possible or might produce an
unreliable result. However, if the sample size within each stratum is sufficient, it is clearly
seen that the pattern-mixture approach provides a good alternative to the inversely weighted
methods and it will be useful in estimation of the CIF when dynamic treatment regimes are
involved.
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4.0 REGRESSION ANALYSIS FOR THE CUMULATIVE INCIDENCE
FUNCTION UNDER TWO-STAGE RANDOMIZATION
4.1 INTRODUCTION
When practitioners deal with time-to-event data, it is always of interest to model or control
for the covariate effects when they are present. Methods that are used for such modeling
purposes have been greatly studied by researchers. The Cox regression model (Cox, 1972)
and the accelerated failure model (Wei et al., 1990; Jin et al., 2003, among others) are two
popular methods of modeling covariate effects on survival outcomes.
Over the years, competing risks became more recognized by practitioners and new meth-
ods were developed to deal with such time-to-event data where the event time is dependently
censored by some competing events. Fine and Gray (1999) extended the Cox regression
model to handle competing risks. They proposed a proportional hazard model for hazard
of sub-distribution which is more commonly called “cumulative incidence function (CIF).”
Fine (2001) proposed a semi-parametric regression for CIF extending the standard log-linear
regression model to competing risks settings. Klein and Andersen (2005) proposed a dif-
ferent model which is based on pseudo values of CIF. Jeong and Fine (2007) introduced a
parametric regression model for CIF using the two-parameter Gompertz model as baseline
CIF. Shi et al. (2013) later developed a modified three-parameter logistic regression model
that outperforms the Gompertz model especially when CIF curves have sigmoidal shapes.
Scheike et al. (2008) extended the Fine and Gray model using direct binomial regression so
that it can handle time-varying coefficients. There is also extensive work on regression anal-
ysis of competing risks data based on the cause-specific hazard functions (Korn and Dorey,
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1992; Cheng et al., 1998; Andersen et al., 2002; Hyun et al., 2009). In this chapter, we focus
on modeling the CIF, since it has a nice probability interpretation and is more appealing to
practitioners.
Although the regression models for time-to-event data have been studied in detail for both
regular and competing-risk censoring, there has not been much research for the two-stage
randomization setting. Murphy (2003) used experimental or observational data to estimate
the best regime that results in a maximal mean response. Zhao et al. (2009) developed a
learning method utilizing Q-learning to choose an optimal policy from a single training data
set. Henderson et al. (2010) proposed a modeling and estimation strategy that incorporates
the regret functions of Murphy (2003) into a regression model for observed responses. More
recently, Goldberg and Kosorok (2012) proposed a method that used survival as an outcome
and focused on finding the treatment policy that maximized the survival function. These
methods focus on choosing the best available treatment regime that will give rise to the best
outcome for an individual with certain characteristics, rather than modeling the effects of
covariates on the survival function or in our case the CIF for a specific treatment regime.
The latter is also of great practical interest, since when a patient is recommended to follow
a specific regime, she may wonder how likely she would have the desirable outcome (e.g.,
no recurrence of breast cancer in five years), given her clinical characteristics. The question
can be addressed by performing regression analysis using the data from the current two-
stage randomization trial. The former endeavors of searching the best treatment regime are
usually based on historical data. Another line of research on regression analysis for dynamic
treatment regimes is to extend the Cox model (Cox, 1972) to two-stage randomization designs
for comparisons of multiple treatment regimes (Lokhnygina and Helterbrand, 2007) which
takes different treatment regimes as a single categorical covariate.
We focus on the approach of directly modeling covariate effects on a survival outcome.
To our best knowledge, there has not been any publications modeling covariate effects on the
CIFs of specific regimes in a two-stage randomized trial. Hence, in this chapter we will carry
out various regression analyses to model covariate effects on the CIF of a specific treatment
regime. More specifically, we will extend the multi-state (Cheng et al., 1998; Andersen et al.,
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2002), Fine and Gray (1999) and Scheike et al. (2008) models for dynamic treatment regimes
using inverse weighting and the pattern-mixture approach and provide detailed simulation
results.
Throughout the chapter we assume there are only two causes of failure, cause 1 event is
the event of interest, and a two-stage randomized trial is being carried out as in Section 2.2.
Also, we assume only patients who are assigned to treatment A1 in the initial assignment are
being considered. In addition to the notation given in Section 2.2, in the following sections,
let X be a covariate vector associated with the occurrence of type 1 event. We define the
conditional CIF given X for treatment regime A1BkB
′
l as F1,A1BkB′l
(t; X) = P (T ≤ t,∆ =
1|X, regime = A1BkB′l).
4.2 THE MULTI-STATE MODEL
4.2.1 The Existing Model
When competing risks are present, the cause-specific CIF can be estimated using the multi-
state model (Cheng et al., 1998; Andersen et al., 2002). More specifically, the Cox model is
applied to evaluate the covariate effects on the cause-specific hazard function. The cause-k
(k = 1, 2) hazard function can be written as
λk(t) = lim
h→0
1
h
P (t ≤ T < t+ h,∆ = k|T ≥ t).
Under the multi-state model it is assumed
λk(t; X) = λ0k(t) exp(β
′
kX), (4.2.1)
where βk is a vector of unknown regression parameters and λ0k(.) is a nonnegative but
otherwise unspecified baseline function for the cause k event. The regression coefficients βk
can be estimated using a partial likelihood principle by treating all the non cause-k failures
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as censored observations. Let Nki(t) = I(Vi ≤ t,∆i = k) and Yi(t) = I(Vi ≥ t). Then the
partial likelihood for βk can be written as
L(βk) =
∏
t
n∏
i=1
(
exp(β
′
kXi)∑n
j=1 exp(β
′
kXj)Yj(t)
)∆Nki(t)
, (4.2.2)
where the first product is over all distinct event times and the second product is over all
subjects. Maximizing this likelihood, it is straightforward to obtain estimates for the re-
gression coefficients. If we let βˆk be the maximum partial likelihood estimates and Λˆk(t) be
the Breslow (Breslow, 1974) estimate for the cumulative cause-k hazard function, then the
cause-1 CIF can be estimated by:
Fˆ1(t; X) =
∫ t
0
Sˆ(u; X)dΛˆ1(u; X) =
n∑
i=1
Sˆ(Vi; X)I(Vi ≤ t,∆i = 1) exp(βˆ ′1X)∑n
j=1 I(Vi ≤ Vj) exp(βˆ ′1Xj)
, (4.2.3)
where Sˆ(u; X) = exp{−∑2k=1 Λˆk(u; X)}, Λˆk(u;x) = Λˆ0k(u) exp(βˆ ′kX) and
Λˆ0k(t) =
∑n
i=1 I(Vi ≤ t,∆i = k)∑n
j=1 I(Vi ≤ Vj) exp(βˆ ′kXj)
.
4.2.2 Extension Using Inverse Weighting
The above likelihood is constructed under the assumption that all the subjects who failed
from cause-1 should contribute to the estimation process equally, independent of the treat-
ment sequence they receive. Under a two-stage randomization setting, when estimating the
regression coefficients for a specific regime, subjects should contribute to this likelihood pro-
portional to their inverse probability weights as in Chapter 2. For this reason, for regime
A1BkB
′
l we propose maximizing the below likelihood for estimating the regression coefficients
associated with cause-1:
LA1BkB′l
(β1) =
∏
t
n∏
i=1
(
exp(β
′
1Xi)∑n
j=1 exp(β
′
1Xj)Y
w
j (t)
)∆Nw1i(t)
, (4.2.4)
where Nw1i(t) = I(Vi ≤ t,∆i = 1)QˆA1BkB′l ,i, Y
w
i (t) = I(Vi ≥ t)QˆA1BkB′l ,i and QˆA1BkB′l ,i =
RiI(Z1i = k)/pˆiBk +(1−Ri)I(Z2i = l)/pˆiB′l as in Chapter 2. Denote the regression coefficients
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obtained by maximizing this weighted likelihood by βˆw1 . Then, the CIF for regime A1BkB
′
l
can be estimated by
Fˆw1 (t; X) =
∫ t
0
Sˆw(u; X)dΛˆw1 (u; X), (4.2.5)
where Sˆw(u; X) = exp{−∑2k=1 Λˆwk (u; X)}, Λˆwk (u; X) = Λˆw0k(u) exp(βˆw′k X) and
Λˆw0k(t) =
∑n
i=1 I(Vi ≤ t,∆i = k)∑n
j=1 I(Vi ≤ Vj) exp(βˆw′k Xj)
.
The implementation of our approach is straightforward using existing R functions. The
estimation of the regression coefficients is carried out by the function “coxph” in the survival
package and the estimated CIF values are obtained with the help of the function “msfit” in
the mstate package. Note that the difference between (4.2.2) and (4.2.4) is the additional
layer of weighting QˆA1BkB′l ,i
. If we use the fixed weights as discussed in Sections 2.3.1 and
2.3.2, those who responded to the initial treatment A1 and were assigned to the subsequent
treatment Bk would receive the same weight, for example 3.3, while those who did not
respond to A1 and were assigned to B
′
l would receive another weight, say 2. Based on these
weights, we create an augmented data set by repeating each of the subjects consistent with
A1Bk 33 times and each of the subjects receiving A1B
′
l 20 times. The R function “coxph” is
applied to analyze the augmented data, and the resulting standard deviations are adjusted
by the squared root of the ratio of the number of subjects in the augmented data to the
number of subjects who were initially assigned to A1. However, for time-varying weights,
the trick may not work. One can write down the likelihood function similar as (4.2.4) with
time-varying weights, and obtain the maximum likelihood estimators using some numerical
methods such as “multiroot” in R.
4.2.3 Pattern-mixture Extension
It is also possible to extend the pattern-mixture approach discussed in Chapter 3 to regression
settings. Recall that the CIF of the regime A1BkB
′
l can be thought of as a linear combination
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of two separate models for patients who followed A1Bk and patients who followed A1B
′
l .
Similar to the decomposition in (3.2.1), we can write:
F1,A1BkB′l
(t; X) = P (R = 1)F1,A1Bk(t; X) + {1− P (R = 1)}F1,A1B′l (t; X). (4.2.6)
Let βˆ1k be the regression coefficient estimates for treatment combination A1Bk ob-
tained by maximizing the likelihood in (4.2.2) for only subjects who received A1Bk and
let Fˆ1,A1Bk(t; X) be the CIF estimate calculated using only the same subset of subjects by
plugging βˆ1k in (4.2.3). Likewise let βˆ1l′ be the regression coefficient estimates for treatment
combination A1B
′
l obtained by maximizing the likelihood in (4.2.2) for only subjects who
received A1B
′
l and let Fˆ1,A1B′l
(t; X) be the CIF estimate calculated using only the same sub-
set of subjects by plugging βˆ1l′ in (4.2.3). Then we propose the regime-specific CIF can be
estimated as a linear combination of these two estimates:
Fˆ1,A1BkB′l
(t; X) = pˆrFˆ1,A1Bk(t; X) + (1− pˆr)Fˆ1,A1B′l (t; X), (4.2.7)
where pˆr is simply the estimated response probability. The analysis in R can be carried out
simply by dividing the data into two parts, the patients who received A1Bk and the patients
who received A1B
′
l , and using the functions “coxph” and “msfit.” After this, the resulting
CIF estimates can be combined as in (4.2.7) and the variance estimates can be combined as
in (3.2.3) to obtain the final results for the regime A1BkB
′
l .
4.3 THE FINE AND GRAY MODEL
4.3.1 The Existing Model
Another popular regression model for a survival outcome subject to competing-risk censoring
was proposed by Fine and Gray (1999) which assumed:
g{F1(t; X)} = h0(t) + β ′X, (4.3.1)
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where g is some fixed transformation function, h0(t) is an invertible and monotonically
increasing function, and β is a parameter vector.
To directly infer the effects of covariates on the CIF, Fine and Gray (1999) considered
the transformation g(u) = log{− log(1−u)} which has a proportional hazards interpretation
for sub-distribution. Define
λ∗1(t; X) = lim
h→0
1
h
P{t ≤ T ≤ t+ h,∆ = 1|T ≥ t ∪ (T ≤ t ∩∆ 6= 1),X}
=
dF1(t; X)/dt
1− F1(t; X) = −
d log{1− F1(t; X)}
dt
, (4.3.2)
which is called the hazard of sub-distribution in Gray (1988). λ∗1 can be thought of as the
hazard function of the improper variable T ∗ = I(∆ = 1)T + (1 − I(∆ = 1))∞. The risk
set associated with this hazard function contains both the subjects who have already failed
from cause 2 event before time t and those who have never failed from any event by t.
When right censoring is present, Fine and Gray (1999) adopted inverse probability cen-
soring weighting (IPCW) in order to obtain an unbiased estimating function. They assumed
censoring time C was independent of T ,  and X, and P (C ≥ t) = G(t). For subject i, they
defined the vital status as ri(t) = I{Ci ≥ (Ti ∧ t)}, where Ti ∧ t = min(Ti, t), and the weight
wi(t) =
ri(t)Gˆ(t)
Gˆ(Vi∧t) , where Gˆ is the Kaplan-Meier estimator for the censoring survival time.
Letting N1i(t) = I(Ti ≤ t,∆i = 1) and Y ∗i (t) = 1 − N1i(t−), they proposed the following
weighted score function for the censored data:
U(β) =
n∑
i=1
∫ ∞
0
[
Xi −
∑
j wj(s)Y
∗
j (s)Xj exp(β
′
Xj)∑
j wj(s)Y
∗
j (s) exp(β
′Xj)
]
wi(s)dN1i(s). (4.3.3)
4.3.2 Extensions Using Inverse Weighting and the Pattern-mixture Approach
When fitting the above regression model under a two-stage randomization setting, we propose
that the individuals should contribute to the partial likelihood function proportional to their
inverse probability weights defined as in Chapter 2 of this dissertation, therefore another
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layer of weighting is required. Below is the formal representation of the proposed score
function for the regime A1BkB
′
l :
UA1BkB′l
(β) =
n∑
i=1
∫ ∞
0
[
Xi −
∑
j wj(s)Y
∗w
j (s)Xj exp(β
′
Xj)∑
j wj(s)Y
∗w
j (s) exp(β
′Xj)
]
wi(s)dN
w
1i(s), (4.3.4)
where Nw1i(t) = I(Ti ≤ t,∆i = 1)QˆA1BkB′l ,i, Y
∗w
i (t) = {1 − I(Ti ≤ t,∆i = 1)}QˆA1BkB′l ,i and
QˆA1BkB′l ,i
are as defined in Chapter 2.
The implementation of our approach is again straightforward using an existing R func-
tion, “crr” in the cmprsk package. Note that the difference between (4.3.3) and (4.3.4) is
just the additional layer of weighting QˆA1BkB′l ,i
. Based on these weights, we again create an
augmented data set by repeating each of the subjects consistent with A1Bk and each of the
subjects receiving A1B
′
l proportional to their weights. The R function “crr” is then applied
to analyze the augmented data to obtain estimates for the regression coefficients and the
CIF. The variance for the CIF estimate is achieved by bootstrapping.
We can also assume the Fine and Gray model for both treatment sequences A1Bk and
A1B
′
l . Then, the CIF estimates for a specific regime can be obtained by splitting the data
consistent with the regime into two parts depending on the treatment combinations they
received and then fitting the Fine and Gray model to each subset of data. Then the estimates
from these two models can be combined as in (4.2.7) to get the pattern-mixture CIF estimate
for the regime. Variance estimates from bootstrapping can also be combined as in (3.2.3) to
obtain a final variance estimate.
4.4 THE SCHEIKE ET AL. MODEL
4.4.1 The Existing Model
Our extensions to the Fine and Gray model are natural when we think about the data
structure of a two-stage randomization setting. However, the proportionality assumption
for sub-distribution hazards in the Fine and Gray model may be too restrictive for a two-
stage randomized trial. During the course of follow-up, the treatment assignment is changed
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depending on a subject’s response to the initial treatment. As a result, the covariate effects
on the CIF may also change. The following generalized model proposed in Scheike et al.
(2008) may be more desirable for the two-stage randomization setting:
g{F1(t; X)} = X′1α(t) + h(X2,γ, t),
where g and h are known link functions, α(t) are time-varying coefficients for a sub-vector of
covariates X1, and X2 are the remaining covariates in X with time-independent coefficients
γ. This model allows for time-varying effects for some covariates and is more flexible than
the Fine and Gray model.
The estimation of the time-independent and time-varying coefficients can be obtained
based on direct binomial regression (Scheike et al., 2008). Let η(t) = (α(t)T ,γT )T , Dη =
∂F1(t; X)/∂η(t) and w(t,X) is some possibly random weight function. Scheike et al. (2008)
proposed the following estimating equation:
U∗(η)(t) =
n∑
i=1
DTη (t; Xi)w(t,Xi)
{
ri(t)N1i(t)
Gˆ(Ti|Xi)
− F1(t; Xi)
}
, (4.4.1)
where Gˆ, ri(t) and N1i are the Kaplan-Meier estimator of the survival function for the
censoring, the vital status indicator, and the cause 1 counting process as defined for the Fine
and Gray model.
4.4.2 Extensions Using Inverse Weighting and the Pattern-Mixture Approach
When the survival data come from a two-stage randomized trial, the subjects who are consis-
tent with the regime of interest should again be weighted to account for those who could have
been consistent with the treatment regime but received different treatment due to the second
stage randomization. Similar to the extension for the Fine and Gray model, we replace N1i
with Nw1i in the estimating equation (4.4.1) which is equivalent to creating an augmented
data set as discussed before. The implementation of this weighted method is immediate by
using the R function “comp.risk” in the package timereg for the Scheike et al. (2008) model
on the augmented data. However, obtaining an estimated variance for the CIF is not that
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straightforward in this case. Due to the complexity of the model based variance, it is not
possible to correct the estimated variance obtained by using the augmented data set. It is
also not feasible to use bootstrapping to get an estimated variance for the CIF due to Scheike
et al. (2008) model’s convergence issues. For these reasons, the simulation results for the
inverse weighted Scheike et al. (2008) model will be provided without coverage rates.
We can also think about this model for a two-stage randomized trial as we did in (4.2.6).
Then, the CIF estimates for a specific regime can be obtained by splitting the data consistent
with the regime into two parts depending on the treatment combinations they received and
then fitting the Scheike et al. model to each subset of data using the function “comp.risk” in
R package timereg. Combining the estimates from these two models as in (4.2.7) will give
us the pattern-mixture CIF estimate for the regime of interest. Variance estimates can also
be combined as before to obtain a final variance estimate.
4.5 SIMULATION STUDIES
4.5.1 Simulations under the Fine and Gray Model
We conduct simulation studies to compare the performance of our proposed methods and
the na¨ıve models in evaluating the covariate effects on the CIFs for two specific regimes
A1B1B
′
1 and A1B1B
′
2. Since it is not possible to directly simulate the data such that the
cause-1 CIFs for both regimes satisfy the proportional hazards model for sub-distribution
in (4.3.1) simultaneously, for the covariates X = (X1, X2) where X1 ∼ Normal(0, 1) and
X2 ∼ Bernoulli(0.5), we assume the following model for the type 1 CIF:
F1(t; X;R;Z1;Z2) = 1− [1− p{1− exp(−t)}]exp(γ1X1+γ2X2), (4.5.1)
where γ1 = R{Z1β11 + (1−Z1)β13}+ (1−R){Z2β12 + (1−Z2)β14} and γ2 = R{Z1β21 + (1−
Z1)β23}+(1−R){Z2β22 +(1−Z2)β24}. In other words when patients are treated with A1B1,
A1B
′
1, A1B2 and A1B
′
2, their CIFs satisfy the Fine and Gray model, and are associated with
(X1, X2) by (β11, β21), (β12, β22), (β13, β23) and (β14, β24) respectively.
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For all sets of simulations, data samples of n = 400 were generated for 2000 times. For the
two regimes, we followed the probabilities of response and subsequent assignments as specified
in scenarios 2 and 3 in Section 2.5. In each setting and each run , first, the two covariates were
generated. Then, the response indicator (R), the second assignment indicator for responders
(Z1) and the second assignment indicator for non-responders (Z2) were generated. Now that
it is known which subject receives which treatment after they receive A1, i.e. B1, B2, B
′
1
or B
′
2, the inversion of the CIFs can be carried out accordingly to obtain event times and
event types as described below. For all settings, the regression coefficients were assumed
to be (β11, β12, β13, β14) = (0.3, 0.7, 0.5, 1.0) and (β21, β22, β23, β24) = (0.2, 0.6, 0.4, 0.9), and
p = 0.4.
Now we describe how to generate event times T and event types  in detail. Based on
n and the simulated R,Z1 and Z2, we calculated the numbers of subjects in all treatment
options, nA1B1 , nA1B2 , nA1B′1
and nA1B′2
. For A1B1, we generated two vectors of uniform
random variables U and V of length nA1B1 . Similar vectors of uniform random variables
were generated for other treatment options. The inverse of the CIF given in (4.5.1) for A1B1
is
F−11,A1B1(u; X) = − log
[
1− 1− (1− u)
exp(−β11X1−β21X2)
p
]
.
For subjects who were treated with A1B1, tmp = 1− (1−U)exp(−β11X1−β21X2) was calculated
and when tmp < p the event time was calculated as T = F−11,A1B1(U ; X) and the event type
was set equal to 1. When tmp ≥ p, the above inverse function did not exist, implying that
the type 2 event occurs before the type 1 event. The conditional distribution of T , given
covariates X and type-2 event occurring first, was modeled as:
P (T ≤ t| = 2,X) = 1− exp{−t exp(β11X1 + β21X2)},
so when tmp ≥ p the event time was calculated as T = − log {(1− V )exp(−β11X1−β21X2)} and
event type was set equal to 2. This algorithm has been used in Cheng (2009) and Cheng and
Fine (2012), among others. The event times and types for the remaining treatment options
were also simulated with their respective uniform random variables and regression coeffi-
cients, following the same simulation strategy. Independent censoring was also introduced
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to the data set. The censoring time was generated from a Uniform(2, 5) distribution which
resulted in ∼ 7% censoring when P (R = 1) = 0.4 and ∼ 6% censoring when P (R = 1) = 0.7.
The observed event time V was then set equal to min(T,C) and the final event type indicator
∆ was set equal to I(T < C).
Since we assumed the proportional sub-distribution hazards model for the CIFs of A1B1,
A1B2, A1B
′
1, and A1B
′
2, the proportional sub-distribution hazards assumption would not hold
if we look at the CIFs for the treatment regimes A1B1B
′
1 and A1B1B
′
2. However, the prior
work by Shi et al. (2013) suggested that the Fine and Gray model can still provide reliable
prediction of the CIF even when the model is misspecified. Hence, in the following tables we
list the average values of the estimated CIFs using the methods described in Sections 4.2,
4.3 and 4.4, evaluated at times 0.5 and 1 for (X1, X2) = (1.5, 1). Let MS, WMS and PMMS
represent the na¨ıve multi-state, inverse weighted multi-state and pattern-mixture multi-state
models; FG, WFG and PMFG represent the original Fine and Gray, inverse weighted Fine
and Gray and pattern-mixture Fine and Gray models; and SC, WSC and PMSC represent
the Scheike et al., inverse weighted Scheike et al. and pattern-mixture Scheike et al. models.
Table 6 contains the results derived from the data sets generated under scenario 2
with n = 400. For the first regime, it can be seen that the na¨ıve, inverse weighted and
pattern-mixture approaches all perform similarly as expected for both event times and both
response rates. However, for the second regime the performance of the na¨ıve approach drops
drastically for all three models. The inverse-weighted and the pattern-mixture extension
models still perform as desired and provide unbiased estimates of the CIF under all cases.
Overall, it can be seen that the WFG and PMFG models perform slightly better than the
respective multi-state and Scheike et al. models under this simulation setting. Also, when
the inverse-weighted and the pattern-mixture approaches are compared, it can be seen that
the pattern-mixture extensions provide slightly better estimates.
Table 7 contains the results derived from the data sets generated under scenario 3 with
n = 400. For both regimes, the na¨ıve models produce biased estimates of the CIFs at both
response rates and both event times. This results in low coverage rates. On the other hand,
inverse weighting and pattern-mixture extensions of all models provide much better results
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with desirable coverage rates. Again, it can be seen that the WFG and PMFG models
perform slightly better than the respective multi-state and Scheike et al. models, when the
underlying models for treatment sequences satisfy the Fine and Gray model. Also, generally
speaking, it can be seen that the pattern-mixture extensions provide slightly better estimates.
4.5.2 Simulations under the Scheike et al. Model
We also evaluated the performance of the proposed estimators in Sections 4.2-4.4 under the
setting where the CIFs of treatment combinations followed Scheike et al. models. To simulate
the data, we assumed two covariates X = (X1, X2) had significant effects on the cause 1 CIF
with X1’s effect varying with time. The CIFs of the treatment combinations that made up
the regimes A1B1B
′
1 and A1B1B
′
2, namely, A1B1, A1B
′
1, A1B2 and A1B
′
2, were assumed to
follow the models below:
F1,A1B1(t; X) = 1− [1− p{1− exp(−t)}]exp[I(t≤t0)β11X1+I(t>t0)β21X1+β31X2],
F1,A1B′1
(t; X) = 1− [1− p{1− exp(−t)}]exp[I(t≤t0)β12X1+I(t>t0)β22X1+β32X2],
F1,A1B2(t; X) = 1− [1− p{1− exp(−t)}]exp[I(t≤t0)β13X1+I(t>t0)β23X1+β33X2],
F1,A1B′2
(t; X) = 1− [1− p{1− exp(−t)}]exp[I(t≤t0)β14X1+I(t>t0)β24X1+β34X2].
To simulate data following these models, first the covariates and response status and random-
ization indicators were generated. Then, for example for a subject who received treatment
combination A1B1, two Uniform variables U and V were generated for the two causes. The
inverse of the above model for A1B1 can be written as:
F−11,A1B1(u; X) =
− log
[
1− 1−(1−u)exp(β11X1+β31X2)
p
]
, if u ≤ tmp1,
− log
[
1− 1−(1−u)exp(β21X1+β31X2)
p
]
, if u > tmp1,
where tmp1 = 1− [1− p{1− exp(−t0)}]exp(β11X1+β31X2). For each subject the two variables,
tmp2 = 1 − (1 − U)exp(β11X1+β31X2) and tmp3 = 1 − (1 − U)exp(β21X1+β31X2) were calculated.
Then if U ≤ tmp1 and p > tmp2, the event time was calculated as T = F−11,A1B1(U ; X) and
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Table 6: Simulations under Fine and Gray- Scenario-2 with n=400: specific time point (t), prob-
ability of response (pr), true cumulative incidence (True), mean of estimates (Mean), empirical
standard deviation (σ˜), mean of estimated standard deviations (σˆ), coverage rate of 95% confi-
dence intervals (Cov)
A1B1B
′
1 A1B1B
′
2
t pr Model True Mean σ˜ σˆ Cov True Mean σ˜ σˆ Cov
0.5 0.4 MS 0.47 0.47 0.09 0.09 0.91 0.62 0.70 0.07 0.06 0.68
WMS 0.47 0.09 0.09 0.91 0.61 0.08 0.06 0.84
PMMS 0.48 0.09 0.08 0.89 0.61 0.06 0.06 0.90
FG 0.45 0.09 0.09 0.92 0.70 0.08 0.07 0.77
WFG 0.45 0.09 0.09 0.92 0.59 0.09 0.09 0.91
PMFG 0.46 0.09 0.09 0.93 0.62 0.06 0.06 0.94
SC 0.45 0.10 0.10 0.92 0.71 0.08 0.07 0.72
WSC 0.45 0.10 – – 0.61 0.09 – –
PMSC 0.47 0.10 0.09 0.91 0.62 0.07 0.06 0.92
0.7 MS 0.37 0.39 0.09 0.08 0.92 0.45 0.55 0.08 0.07 0.70
WMS 0.39 0.09 0.08 0.92 0.45 0.09 0.07 0.88
PMMS 0.39 0.09 0.08 0.91 0.46 0.07 0.07 0.92
FG 0.36 0.09 0.09 0.92 0.53 0.09 0.09 0.85
WFG 0.36 0.09 0.09 0.93 0.42 0.09 0.09 0.90
PMFG 0.37 0.08 0.08 0.93 0.45 0.07 0.07 0.93
SC 0.36 0.09 0.09 0.92 0.55 0.09 0.09 0.81
WSC 0.36 0.09 – – 0.43 0.09 – –
PMSC 0.38 0.09 0.08 0.91 0.45 0.08 0.07 0.93
1 0.4 MS 0.64 0.63 0.09 0.08 0.90 0.75 0.82 0.05 0.04 0.52
WMS 0.63 0.09 0.08 0.90 0.75 0.07 0.05 0.82
PMMS 0.63 0.08 0.07 0.90 0.72 0.06 0.05 0.83
FG 0.63 0.10 0.10 0.92 0.86 0.06 0.05 0.45
WFG 0.63 0.10 0.10 0.92 0.77 0.08 0.08 0.87
PMFG 0.63 0.09 0.09 0.94 0.75 0.06 0.06 0.91
SC 0.64 0.11 0.10 0.92 0.87 0.06 0.05 0.37
WSC 0.64 0.10 – – 0.78 0.08 – –
PMSC 0.64 0.10 0.09 0.92 0.75 0.07 0.06 0.89
0.7 MS 0.53 0.55 0.09 0.08 0.89 0.59 0.70 0.07 0.06 0.53
WMS 0.55 0.09 0.08 0.89 0.60 0.08 0.07 0.85
PMMS 0.54 0.09 0.08 0.90 0.58 0.08 0.07 0.89
FG 0.53 0.10 0.10 0.93 0.70 0.08 0.08 0.67
WFG 0.53 0.10 0.10 0.93 0.59 0.09 0.09 0.93
PMFG 0.53 0.09 0.09 0.93 0.58 0.08 0.08 0.92
SC 0.53 0.11 0.10 0.92 0.72 0.09 0.08 0.62
WSC 0.53 0.11 – – 0.60 0.10 – –
PMSC 0.54 0.10 0.09 0.92 0.59 0.09 0.08 0.91
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Table 7: Simulations under Fine and Gray- Scenario-3 with n=400: specific time point (t), prob-
ability of response (pr), true cumulative incidence (True), mean of estimates (Mean), empirical
standard deviation (σ˜), mean of estimated standard deviations (σˆ), coverage rate of 95% confi-
dence intervals (Cov)
A1B1B
′
1 A1B1B
′
2
t pr Model True Mean σ˜ σˆ Cov True Mean σ˜ σˆ Cov
0.5 0.4 MS 0.47 0.42 0.06 0.05 0.85 0.62 0.51 0.06 0.06 0.51
WMS 0.47 0.06 0.06 0.91 0.60 0.06 0.06 0.90
PMMS 0.48 0.06 0.06 0.91 0.61 0.05 0.05 0.92
FG 0.40 0.06 0.06 0.75 0.49 0.07 0.07 0.48
WFG 0.45 0.06 0.06 0.92 0.59 0.07 0.07 0.92
PMFG 0.47 0.06 0.06 0.92 0.62 0.05 0.05 0.93
SC 0.40 0.06 0.06 0.77 0.50 0.07 0.07 0.57
WSC 0.45 0.07 – – 0.60 0.07 – –
PMSC 0.46 0.07 0.07 0.93 0.62 0.06 0.05 0.92
0.7 MS 0.37 0.35 0.05 0.05 0.90 0.45 0.39 0.05 0.05 0.70
WMS 0.38 0.05 0.05 0.92 0.45 0.06 0.05 0.91
PMMS 0.39 0.05 0.05 0.90 0.46 0.05 0.04 0.92
FG 0.33 0.05 0.05 0.79 0.36 0.05 0.05 0.55
WFG 0.36 0.05 0.05 0.92 0.42 0.06 0.06 0.90
PMFG 0.37 0.06 0.05 0.92 0.45 0.05 0.05 0.94
SC 0.32 0.05 0.05 0.79 0.36 0.06 0.05 0.60
WSC 0.36 0.06 – – 0.43 0.07 – –
PMSC 0.37 0.06 0.06 0.91 0.45 0.05 0.05 0.93
1 0.4 MS 0.64 0.59 0.06 0.05 0.80 0.75 0.67 0.06 0.05 0.62
WMS 0.64 0.06 0.05 0.90 0.74 0.05 0.04 0.90
PMMS 0.63 0.05 0.05 0.92 0.72 0.04 0.04 0.84
FG 0.58 0.07 0.06 0.82 0.67 0.07 0.07 0.77
WFG 0.64 0.07 0.06 0.93 0.76 0.06 0.06 0.92
PMFG 0.64 0.06 0.06 0.93 0.74 0.04 0.04 0.94
SC 0.58 0.07 0.07 0.83 0.68 0.07 0.07 0.83
WSC 0.64 0.07 – – 0.78 0.06 – –
PMSC 0.64 0.06 0.06 0.93 0.74 0.04 0.04 0.94
0.7 MS 0.53 0.51 0.05 0.05 0.88 0.59 0.54 0.06 0.05 0.81
WMS 0.54 0.06 0.05 0.90 0.60 0.06 0.05 0.89
PMMS 0.54 0.05 0.05 0.90 0.58 0.05 0.04 0.92
FG 0.49 0.06 0.06 0.84 0.52 0.06 0.06 0.79
WFG 0.53 0.06 0.06 0.93 0.59 0.06 0.06 0.93
PMFG 0.53 0.06 0.05 0.94 0.58 0.05 0.05 0.93
SC 0.49 0.06 0.06 0.84 0.53 0.06 0.06 0.80
WSC 0.53 0.07 – – 0.60 0.07 – –
PMSC 0.53 0.06 0.06 0.93 0.58 0.05 0.05 0.94
53
event type was set equal to 1. Similarly, if U > tmp1 and p > tmp3, the event time was
calculated as T = F−11,A1B1(U ; X) and event type was set equal to 1.
For the case where U ≤ tmp1 but p ≤ tmp2, the CIF was modeled as:
P (T ≤ t| = 2,X) = 1− exp{−t exp(β11X1 + β31X2)},
and to obtain the event time it was inverted as T = − log {(1− V )exp(−β11X1−β31X2)} and the
event type was set equal to 2. Similarly, for the case where U > tmp1 but p ≤ tmp3 the CIF
was modeled as:
P (T ≤ t| = 2,X) = 1− exp{−t exp(β21X1 + β31X2)},
and to obtain the event time it was inverted as T = − log {(1− V )exp(−β21X1−β31X2)} and the
event type was again set equal to 2. For the other three treatment combinations similar data
generation procedures were followed. The regression coefficients associated with X1 were
chosen as (β11, β12, β13, β14) = (0.3, 0.7, 0.5, 1.0), (β21, β22, β23, β24) = (0.5, 0.9, 0.7, 1.2) and
the ones associated with X2 were set as (β31, β32, β33, β34) = (0.2, 0.6, 0.4, 0.9) where p = 0.4.
The time point where the effect of X1 was assumed to change, t0, was set equal to 0.75.
Independent censoring was introduced to the data set by generating the censoring time C
from a Uniform(2, 4) distribution and letting V = min(T,C) and ∆ = I(T < C) resulted
in ∼ 10% censoring for P (R = 1) = 0.4 and ∼ 9% censoring for P (R = 1) = 0.7. The
data generation process was repeated for cases P (R = 1) = 0.4 and P (R = 1) = 0.7 and for
scenarios 2 and 3 in Section 2.5. In the following tables we list the average estimated CIF
values evaluated at times 0.5 and 1 for (X1, X2) = (1.5, 1).
Again, we let MS, WMS and PMMS represent the na¨ıve multi-state, inverse weighted
multi-state and pattern-mixture multi-state models; FG, WFG and PMFG represent the
na¨ıve Fine and Gray, inverse weighted Fine and Gray and pattern-mixture Fine and Gray
models; and SC, WSC and PMSC represent the Scheike et al., inverse weighted Scheike et
al. and pattern-mixture Scheike et al. models.
Table 8 is a summary of the results obtained under scenario 2. For the first regime it can
be seen that the pattern-mixture and inverse weighted methods perform similar to the na¨ıve
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method for both event times and both response rates as expected. However for the second
regime, the na¨ıve models fail to generate unbiased estimates for the CIF and fail to achieve
desirable coverage rates. The proposed extensions on FG and SC models all perform much
better for both event times and both response rates. Overall it can be seen that extensions of
SC models produce estimates that are slightly closer to the true values, when the underlying
CIFs for treatment combinations follow the Scheike et al. model.
Table 9 is a summary of the results obtained under scenario 3. Under this scenario the
comparison of the methods for the two specific time points are different. For t = 0.5 it can
be seen that the na¨ıve MS model is performing slightly better compared to the extensions,
the FG model performs similar to the extensions, and WSC and PMSC models perform
much better compared to the na¨ıve SC model. However, as we look at the second time point
t = 1 and as a result we include more data points in the analysis, it can be seen that for all
models the extensions work much better for both regimes under all conditions compared to
the original models.
Looking at the results from both scenarios, we can say that when the data is suspected
to involve a covariate with a time-varying effect like under the Scheike et al. model, it is
much safer to fit the WSC and PMSC models with a slight preference towards PMSC if
there are adequate data in each stratum. Even if one is not aware of the time-varying effect,
the proposed extensions of MS and FG models are still much safer alternatives compared to
the na¨ıve approaches.
4.6 SUMMARY
In this chapter we proposed two extensions, inverse weighting and pattern-mixture, on three
existing regression models on the CIF which can be used when dynamic treatment regimes
are of interest and a two-stage randomization is carried out. The inferences for the proposed
extension models are simple and the analysis can be carried out by slightly manipulating
existing R packages. We showed that the proposed extension models produce more reliable
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Table 8: Simulations under Scheike et al.- Scenario-2 with n=400: specific time point (t), probability
of response (pr), true cumulative incidence (True), mean of estimates (Mean), empirical standard
deviation (σ˜), mean of estimated standard deviations (σˆ), coverage rate of 95% confidence intervals
(Cov)
A1B1B
′
1 A1B1B
′
2
t pr Model True Mean σ˜ σˆ Cov True Mean σ˜ σˆ Cov
0.5 0.4 MS 0.47 0.52 0.09 0.09 0.89 0.62 0.73 0.06 0.06 0.51
WMS 0.52 0.09 0.09 0.89 0.64 0.08 0.06 0.83
PMMS 0.52 0.09 0.08 0.85 0.64 0.06 0.06 0.91
FG 0.50 0.10 0.09 0.91 0.74 0.07 0.07 0.58
WFG 0.50 0.10 0.09 0.91 0.64 0.09 0.08 0.90
PMFG 0.52 0.09 0.09 0.89 0.65 0.06 0.06 0.91
SC 0.47 0.12 0.11 0.91 0.72 0.09 0.08 0.71
WSC 0.47 0.12 – – 0.62 0.10 – –
PMSC 0.49 0.12 0.11 0.88 0.63 0.09 0.07 0.89
0.7 MS 0.37 0.44 0.09 0.08 0.88 0.45 0.59 0.08 0.07 0.52
WMS 0.44 0.09 0.08 0.88 0.50 0.08 0.07 0.86
PMMS 0.44 0.08 0.08 0.85 0.50 0.07 0.07 0.90
FG 0.42 0.09 0.09 0.93 0.58 0.08 0.08 0.67
WFG 0.42 0.09 0.09 0.93 0.48 0.09 0.09 0.93
PMFG 0.43 0.08 0.08 0.92 0.49 0.07 0.07 0.91
SC 0.38 0.11 0.10 0.91 0.56 0.10 0.10 0.79
WSC 0.38 0.11 – – 0.45 0.10 – –
PMSC 0.39 0.11 0.11 0.90 0.46 0.09 0.09 0.91
1 0.4 MS 0.73 0.70 0.08 0.07 0.90 0.80 0.85 0.04 0.04 0.68
WMS 0.70 0.08 0.07 0.90 0.79 0.06 0.04 0.85
PMMS 0.69 0.08 0.07 0.86 0.75 0.06 0.05 0.80
FG 0.72 0.09 0.09 0.92 0.90 0.05 0.04 0.42
WFG 0.72 0.09 0.09 0.91 0.82 0.07 0.07 0.85
PMFG 0.71 0.08 0.08 0.93 0.79 0.06 0.06 0.89
SC 0.74 0.11 0.10 0.90 0.93 0.05 0.04 0.29
WSC 0.74 0.11 – – 0.85 0.08 – –
PMSC 0.74 0.10 0.09 0.90 0.80 0.08 0.07 0.85
0.7 MS 0.63 0.62 0.08 0.08 0.92 0.67 0.75 0.06 0.05 0.63
WMS 0.62 0.08 0.08 0.92 0.67 0.08 0.06 0.86
PMMS 0.61 0.08 0.08 0.90 0.65 0.08 0.07 0.90
FG 0.62 0.10 0.09 0.92 0.77 0.07 0.07 0.64
WFG 0.62 0.10 0.09 0.92 0.68 0.09 0.09 0.90
PMFG 0.61 0.09 0.09 0.92 0.65 0.08 0.08 0.91
SC 0.64 0.11 0.11 0.91 0.80 0.09 0.08 0.57
WSC 0.64 0.11 – – 0.69 0.10 – –
PMSC 0.64 0.11 0.10 0.90 0.67 0.10 0.09 0.90
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Table 9: Simulations under Scheike et al.- Scenario-3 with n=400: specific time point (t), probability
of response (pr), true cumulative incidence (True), mean of estimates (Mean), empirical standard
deviation (σ˜), mean of estimated standard deviations (σˆ), coverage rate of 95% confidence intervals
(Cov)
A1B1B
′
1 A1B1B
′
2
t pr Model True Mean σ˜ σˆ Cov True Mean σ˜ σˆ Cov
0.5 0.4 MS 0.47 0.47 0.06 0.06 0.95 0.62 0.56 0.06 0.06 0.76
WMS 0.51 0.06 0.06 0.85 0.64 0.06 0.05 0.89
PMMS 0.52 0.06 0.06 0.82 0.64 0.05 0.04 0.88
FG 0.45 0.06 0.06 0.94 0.54 0.07 0.06 0.76
WFG 0.50 0.06 0.06 0.91 0.64 0.07 0.06 0.93
PMFG 0.52 0.06 0.06 0.85 0.65 0.05 0.05 0.84
SC 0.41 0.07 0.07 0.84 0.52 0.08 0.07 0.69
WSC 0.46 0.08 – – 0.62 0.08 – –
PMSC 0.46 0.08 0.07 0.93 0.62 0.06 0.06 0.90
0.7 MS 0.37 0.40 0.05 0.05 0.93 0.45 0.44 0.05 0.05 0.92
WMS 0.43 0.05 0.05 0.77 0.49 0.06 0.05 0.84
PMMS 0.44 0.05 0.05 0.73 0.50 0.05 0.04 0.75
FG 0.38 0.05 0.05 0.95 0.42 0.05 0.05 0.87
WFG 0.42 0.05 0.05 0.88 0.48 0.05 0.06 0.93
PMFG 0.43 0.05 0.05 0.82 0.49 0.05 0.05 0.81
SC 0.33 0.06 0.06 0.86 0.37 0.06 0.06 0.72
WSC 0.37 0.07 – – 0.44 0.07 – –
PMSC 0.38 0.07 0.06 0.92 0.45 0.06 0.05 0.94
1 0.4 MS 0.73 0.65 0.05 0.05 0.64 0.80 0.72 0.05 0.04 0.55
WMS 0.70 0.05 0.05 0.90 0.79 0.04 0.04 0.89
PMMS 0.69 0.05 0.04 0.86 0.76 0.04 0.03 0.74
FG 0.66 0.06 0.06 0.79 0.74 0.06 0.06 0.84
WFG 0.72 0.06 0.06 0.95 0.82 0.05 0.05 0.89
PMFG 0.72 0.05 0.05 0.95 0.79 0.04 0.04 0.92
SC 0.67 0.07 0.07 0.87 0.76 0.07 0.07 0.90
WSC 0.73 0.07 – – 0.85 0.06 – –
PMSC 0.73 0.06 0.06 0.94 0.80 0.04 0.04 0.93
0.7 MS 0.63 0.58 0.05 0.05 0.82 0.67 0.61 0.05 0.05 0.78
WMS 0.62 0.05 0.05 0.92 0.67 0.05 0.04 0.90
PMMS 0.61 0.05 0.05 0.92 0.65 0.04 0.04 0.90
FG 0.58 0.06 0.06 0.84 0.61 0.06 0.06 0.84
WFG 0.62 0.06 0.06 0.94 0.67 0.06 0.06 0.93
PMFG 0.62 0.05 0.05 0.94 0.65 0.05 0.05 0.93
SC 0.58 0.07 0.06 0.88 0.62 0.07 0.06 0.87
WSC 0.63 0.07 – – 0.69 0.07 – –
PMSC 0.63 0.06 0.06 0.94 0.66 0.05 0.05 0.92
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estimates for the CIF under a two-stage randomization setting for various conditions using
simulation. In general the pattern-mixture extensions of all three models perform slightly
better so they should be preferred over the inverse weighted extensions when there are
adequate data in each subgroup. We conclude that when there are time-varying effects on
the CIF it is safer to fit the extensions of the Scheike et al. model. Overall, regardless of
the nature of data, the proposed extensions provide a more reliable way to analyze covariate
effects on the CIF of a dynamic treatment regime and should be preferred over the existing
na¨ıve models.
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5.0 REMARKS AND FUTURE WORK
In this dissertation, we focused on two-stage dynamic treatment regimes under the presence
of competing risks. The methods provide unbiased estimation of the CIF which facilitates
the comparison of dynamic treatment regimes and, as a result, helps choose the best regime
that results in minimal chance of experiencing the failure of interest. Both inverse proba-
bility weighting and pattern-mixture estimators work well, and we provide explicit variance
estimators which make inference straightforward. There is not much difference between the
two approaches except when there are inadequate number of subjects receiving a specific
treatment combination which may make the pattern-mixture estimator unreliable if it is
calculable. Other than that, the choice simply depends on researchers’ familiarity with the
two approaches.
We also provide methods to extend existing regression models on the CIF to dynamic
treatment regimes. They will be useful in directly evaluating covariate effects on the CIF for
a specific regime. The extended models can easily be applied to any data set using existing
packages. Both extensions work much better than na¨ıvely fitting a model on all the subjects
who are consistent with a specific regime with pattern-mixture extensions working slightly
better. This is expected. The models considered in Chapter 4 are more likely to hold on the
treatment sequence level than on the regime level which is more heterogeneous regarding the
mixture of responders and non-responders.
In this dissertation, we have focused on survival outcomes subject to competing-risk cen-
soring. The methods provided in this dissertation will also be useful even when there are no
competing risks. The same approaches can be taken on extending regression models for typ-
ical survival outcomes and more general continuous outcomes. Developing such models will
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be very useful for comparison of dynamic treatment regimes and evaluating covariate effects
on a specific regime with respect to different types of outcomes. It may also be desirable
to develop model selection procedures that would work under a two-stage randomization to
help choose the most effective covariates on these outcomes. These may be future research
topics.
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